LaunchRobotic Connective Network
Nightfood
Nightfood Holdings Inc. (OTCQB: NGTF), operating under the TechForce Robotics brand, is engineering a solution to this problem with a proprietary Robotic Connective Network and…
Robotics
The Palo Alto edition · 2026
Palo Alto · Photo: Wikimedia Commons (CC BY-SA 3.0)Life sciencescompanies in Palo Alto
Life sciences technology, oncology, genomics, neurology and cardiac, startups and more: the companies building life sciences in Palo Alto, California, with their founders, funding, team size and business models.
140 company profiles52 with recorded fundingNovember 2026 edition
Recent life sciences business events in the United States
Funding, M&A, contract wins and launches involving 27,407 life sciences companies in the United States, last 24 months: 1640 M&A deals · 1543 funding rounds · 557 Contracts · 73 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jul 2026.
ContractInfrastructure
Sharp · client: Kddi
Electronics company Sharp is working with telco KDDI to build what it claims will be Asia's largest AI data center on the site of a former LCD screen manufacturing plant in Osaka, Japan.
AI data center
M&AAcquisition · Completed
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquires Mineralys therapeutics
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquired a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) during the fourth quarter, according to its…
Clinical-stage biopharmaceutical
M&AMerger · Announced
Ignite acquires Ignite Proteomics
The transaction values Ignite at an implied equity value of approximately $150 million, subject to the terms and conditions of the business combination agreement.
Functional proteomics
ContractTechnology
Chai Discovery · client: Pfizer
Pfizer announced a licensing agreement with Chai Discovery that gives it early access to the new Chai-3 AI platform, which could improve its ability to identify and design new drug…
Biopharmaceutical
FundingSenior Notes
IQVIA
IQVIA Holdings Inc. ('IQVIA') (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the 'Issuer'), priced an offering of €950,000,000 in aggregate principal amount of…
ContractSupply
Beijing mabworks biotech · client: Everest medicines
Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…
Pharmaceutical
FundingSeries B
Advanced nanotherapies
Advanced NanoTherapies (ANT) has successfully closed a significant Series B funding round, garnering over $31 million.
Investors S3 Ventures, T45 Fund
Medical device
FundingRegistered Direct Offering
Lixte Biotechnology Holdings
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in…
Investors Accredited investors
Pharmaceutical
ContractService
Hollister-Stier Laboratories LLC · client: Biomarin pharmaceutical
Hollister-Stier has agreed to filter and package an enzyme-replacement product for BioMarin Pharmaceutical Inc., of Novato, Calif.
Pharmaceutical
M&AAcquisition · Announced
Resmed acquires Noctrix health
announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE: RMD), a global leader in sleep health and respiratory care, in a transaction valued at $340 million.
Medical technology
M&AMerger · Completed
B&C Telephone Inc. acquires Intouch solutions
B&C Telephone Inc., a Spokane-based company that sells and services commercial telephone systems, has merged with inTouch Solutions, a Boise-based telecommunication company.
Telecommunications
M&AAcquisition · Announced
The clorox company acquires Nutranext
Clorox will pay $700 million to acquire Nutranext, with the purchase price representing about 3.5 times calendar year 2017 sales.
Dietary and Nutritional Supplements
ContractService
Stellantis · client: Evera
With this agreement, Evera aims to rent 2,000 electric vehicles reconditioned by the Stellantis group by the end of 2027.
FundingMinority Stake Investment
Omniactive health technologies
Everstone Group has invested $35 million in a stake of Mumbai-based OmniActive Health Technologies Ltd.
Investors Everstone group
Nutraceutical
M&AAcquisition · Announced
Butterfly acquires Orgain
Butterfly, a LA-based private equity firm specializing in the food sector, has signed a definitive agreement to acquire a majority stake in Orgain, Inc., according to a press release.
Organic and clean nutrition products
FundingUnderwritten Offering
Mineralys therapeutics
The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be…
Biopharmaceutical
FundingSeries B
Triomics
Triomics has raised USD $22 million in Series B funding in a round led by Battery Ventures.
Cancer-focused artificial intelligence
M&AAcquisition · Pending
Medtronic acquires Spr therapeutics
is currently finalizing the purchase of SPR Therapeutics
Medical device manufacturer
FundingPublic Offering
Avalo therapeutics
In first place was Avalo Therapeutics, which priced a $375 million public offering to advance the clinical development of its candidate abdakibart, including through its phase 3 topline…
Investors Na
Biotech
FundingPublic Offering
Editas medicine
In second place, gene editing company Editas Medicine announced a public offering of up to $319.4 million.
Investors Na
Biotech
FundingSeries A
Endra
Stockholm-based AI startup Endra has raised $50 million in Series A funding to scale its platform that automates design work for mechanical, electrical, and plumbing (MEP) consultants.…
AI
M&AAcquisition · Announced
Tend health acquires The doctors
Green Cross Health surged by more than a third after it agreed to sell its medical arm, The Doctors, to iwi-backed digital-first health firm Tend Health for $270 million.
Healthcare
LaunchVOXLS 20 C 225
Nikon Corporation
Nikon Corporation has launched the VOXLS 20 C 225, the latest addition to its VOXLS X-ray CT product lineup.
X-ray CT
FundingPublic Offering
Nrx pharmaceuticals
NRx Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock in an underwritten public offering with BTIG, LLC acting as the lead bookrunner and Lucid…
Biopharmaceutical
FundingNon-dilutive Capital
Apogee therapeutics
Apogee Therapeutics secured up to $1.3 billion in flexible, non-dilutive capital last month from Blackstone Life Sciences, including up to $800 million in synthetic royalty and access to…
Investors Blackstone Life Sciences
Biotech
FundingPublic Offering
Artiva biotherapeutics
It's also worth noting that Artiva Biotherapeutics wasn't far behind in fourth place after pricing a $300 million underwritten offering.
Investors Na
Biotech
M&AMerger · Announced
Avenzo therapeutics acquires Rallybio
NEW YORK – Rallybio will merge with Avenzo Therapeutics to develop several precision oncology assets, including CDK2 and CDK4 inhibitors and bispecific antibody-drug conjugates (ADCs).
Oncology
M&AAcquisition · Announced
Dragos acquires Phosphorus
Dragos has acquired Phosphorus, broadening its reach across connected devices in operational environments.
Cybersecurity / device discovery and remediation software
M&AAcquisition · Announced
Rallybio acquires Avenzo therapeutics
Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a…
Biotech
Life sciences companies in Palo Alto, by funding and team
Few life sciences companies in Palo Alto, California publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 140 active companies.
Provider of a cloud based clinical trail management tool for researchers
Life sciences techUS$518.45mSeries D · Oct 2021
341+198% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
14 yr2012
0none in 3 months · last posted Nov 2025
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 376
- Recorded funding
- US$518.45m · Series D · Oct 2021
- Founded
- 2012 · about 14 years old
- Stage
- Series D
- Focus
- Research & development, Clinical trials, Study implementation, Ctms and edc
Funding over time
US$518.45m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 3
James SasCo-Founder
Tim SmithCo-Founder, CTO
- Highest education
- Bachelor's · The University Of Texas At Austin
Michelle LongmireCo-Founder & CEO
- Highest education
- Stanford University School Of Medicine
Investors · 8
BlackstoneFund
GSR VenturesFund
Obvious VenturesFund
PPDFund
WTIFund
Team & hiring signals
LinkedIn headcount341501-1,000
LinkedIn followers120,886
Earlier recorded team3762022, a different source
Open roles1of 3 tracked · last posted Nov 2025
Patents
Patent filings14
Focus: Digital health data integration, remote patient monitoring, and HIPAA compliance automation
CPC G16H50/20, G06Q10/0639, G16H80/00Mobile apps
- MedableMedical · 4,345 installs · ★ 4.0 · updated 2026-06-05
- ZEUS Study App (EX6018-4758)Medical · 3,456 installs · updated 2024-10-08
- P23-899 PatientMedical · 673 installs · updated 2025-03-10
Technology
AWS
React
Nginx
Cloudflare
HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Genetically engineered yeast cells to produce medicinal products
GenomicsUS$176.37mSeries C · Jan 2026
66+35% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
13 yr2013
0none in 3 months · last posted Jun 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50 (previous snapshot 61)
- Recorded funding
- US$176.37m · Series C · Jan 2026
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- Applied genomics, Synthetic biology, Research services, Diversified
Funding over time
US$176.37m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Christina SmolkeCo-Founder & CEO
- Highest education
- Doctor of Philosophy · The University of California
Kristy HawkinsCo-Founder & CSO
Investors · 11
EDBIFund
EchoFund
In-Q-TelFund
S-Cubed CapitalFund
Team & hiring signals
LinkedIn headcount6651-200
LinkedIn followers9,936
Earlier recorded team502022, a different source
Open roles1of 7 tracked · last posted Jun 2026
- Hiring: Associate Director of Global Quality
Recent company signals
- Leadership Hired a VP of Drug Innovation and Managing Director
Patents
Patent filings82
Focus: Biotechnological production and optimization of opioid alkaloids (benzylisoquinoline and morphinan)
CPC C12N15/52, C12P17/182, C12P17/12Technology
PHP
MySQL- Cloudflare
WordPress
jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of biotherapeutic solutions for cancer treatment
OncologyUS$169.85mSeries D · Sep 2022
34+59% 12 mo to Dec 2021LinkedIn · Jul 2026
E-commerce - product / Physical commerce
11 yr2015
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 89
- Recorded funding
- US$169.85m · Series D · Sep 2022
- Founded
- 2015 · about 11 years old
- Stage
- Series D
- Focus
- Drugs, Diversified
Funding over time
US$169.85m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dongxu SunCEO
- Highest education
- Doctorates in philosophy · University Of Minnesota
Team & hiring signals
LinkedIn headcount3451-200
LinkedIn followers5,790
Earlier recorded team892021, a different source
Recent company signals
- Milestone 380 patients enrolled
- Milestone more than 50% patients recruited
Patents
Patent filings80
Focus: Therapeutic antibodies targeting Galectin‑3 and protein‑aggregation inhibition for disease treatment
CPC C07K16/2851, C07K16/2803, A61P31/14Technology
Angular
TypeScript- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for multiple metabolic diseases
DiabetesUS$153.33mSeries B · Feb 2025
17+11% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
5 yr2021
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10 (previous snapshot 9)
- Recorded funding
- US$153.33m · Series B · Feb 2025
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$153.33m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mani SubramanianFounder & CEO
- Highest education
- Doctor of Philosophy · University of Michigan
Investors · 7
Ascenta CapitalFund
Enavate SciencesFund
LillyFund
NuevaBioFund
Team & hiring signals
LinkedIn headcount1711-50
LinkedIn followers3,330
Patents
Patent filings45
Focus: Small-molecule LXR modulators and ACMSD inhibitors for dyslipidemia and metabolic disease therapy
CPC C07D409/04, C07C311/14, C07D409/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Immunotherapy to develop and deliver medicines for cardiovascular disease
Cardiac and vascular disordersUS$145.00mSeries A · Jun 2023
29LinkedIn · Jul 2026
Physical commerce
5 yr2021
0none in 3 months · last posted Jun 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12
- Recorded funding
- US$145.00m · Series A · Jun 2023
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Drugs, Coronary artery diseases, Diversified, Immuno oncology
Founders · 3
Irving WeissmanCo-Founder
- Highest education
- Stanford University
Lou LangeCo-Founder
- Highest education
- Doctor of Philosophy · Harvard University
Nicholas LeeperCo-Founder
- Highest education
- The University of Chicago
Investors · 5
DeerfieldFund
Google VenturesFund
Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers3,895
Earlier recorded team122022, a different source
Open roles0of 1 tracked · last posted Jun 2025
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of RNA biomarkers and AI platform for cancer detection
OncologyUS$138.15mSeries B · Oct 2022
22-15% vs previous recordLinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted May 2026
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 47 (previous snapshot 55)
- Recorded funding
- US$138.15m · Series B · Oct 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- In-vitro diagnostic tests, Diversified
Funding over time
US$138.15m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Babak AlipanahiCo-Founder & Chief Scientific Officer
- Highest education
- Computer Science · University of Waterloo
Hani GoodarziCo-Founder
Investors · 3
Casdin CapitalFund
S32Fund
Team & hiring signals
LinkedIn headcount2251-200
LinkedIn followers6,287
Open roles1of 1 tracked · last posted May 2026
Recent company signals
- Partnership Partnership with Deviation Capital
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of antibodies to target immune system and tumor microenvironment
ImmunotherapyUS$138.00mSeries B · Jan 2023
12+20% 12 mo to Dec 2022LinkedIn · Jul 2026
Fee-for-service
10 yr2016
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 24 (previous snapshot 46)
- Recorded funding
- US$138.00m · Series B · Jan 2023
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$138.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Charlene LiaoFounder & CEO
- Highest education
- Northwestern University - Kellogg School Of Management
Investors · 12
CLI VenturesFund
Proxima VenturesFund
Triwise CapitalFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers4,018
Earlier recorded team242022, a different source
Technology
- Cloudflare
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Drug for treatment of chronic kidney disease
Metabolic diseasesUS$131.00mPE · Jul 2005
72recorded
E-commerce - product / Physical commerce
25 yr2001
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 72
- Recorded funding
- US$131.00m · PE · Jul 2005
- Founded
- 2001 · about 25 years old
- Stage
- Public
- Focus
- Drugs, Renal disorders
Funding over time
US$131.00m across 3 disclosed equity rounds
Darker bars = larger roundsInvestors · 4
ApaxFund
Credit SuisseFund- MPM CapitalFund
Bear Stearns CompaniesFund
Patents
Patent filings162
Focus: Erythropoietin receptor agonist peptides and PEGylated peptide drug delivery technologies
CPC C07K14/505, C07K14/001, A61K38/1816Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
AI-based RNA molecular modeling tool for the vaccine
Life sciences techUS$120.00mSeries A · Sep 2023
55+17% vs previous recordLinkedIn · Oct 2026
Subscription
5 yr2021
0none in 3 months · last posted Apr 2025
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 35 (previous snapshot 30)
- Recorded funding
- US$120.00m · Series A · Sep 2023
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Vaccine discovery, Ai based
Funding over time
US$120.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jakob UszkoreitCo-Founder & CEO
- Highest education
- TU Berlin
Investors · 3
- Obvious VenturesFund
NVIDIAFund
Team & hiring signals
LinkedIn headcount5511-50
LinkedIn followers10,432
Open roles0of 1 tracked · last posted Apr 2025
Recent company signals
- Partnership Partnership with Alnylam Pharmaceuticals
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of medical devices for treating mitral valve regurgitation
Cardiac and vascular disordersUS$115.00mSeries C · Mar 2026
25LinkedIn · Jul 2026
Physical commerce
16 yr2010
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 20
- Recorded funding
- US$115.00m · Series C · Mar 2026
- Founded
- 2010 · about 16 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Valvular diseases
Funding over time
US$115.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacques EssingerFounder & CEO
- Highest education
- PhD · EPFL
Investors · 8
Decheng CapitalFund
EarlybirdFund
Endeavour VisionFund
- LuminationFund
IDO InvestmentsFund- DC Global VenturesFund
Team & hiring signals
LinkedIn headcount2511-50
LinkedIn followers745
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of DNA chips and molecular assays
GenomicsUS$103.30mSeries C · Jul 2018
23-8% 12 mo to Dec 2022recorded Dec 2022
Fee-for-service
17 yr2009
0none in 3 months · last posted May 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 36)
- Recorded funding
- US$103.30m · Series C · Jul 2018
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Research services, Genomics, Genomics services, Full service
Funding over time
US$86.80m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Wei ZhouFounder & CEO
- Highest education
- Leadership · Harvard Business School
Investors · 1
WeDoctorFund
Team & hiring signals
Open roles4of 23 tracked · last posted May 2026
Patents
Patent filings6
Focus: High-throughput DNA sequencing reagents, microarray fabrication, and surface-modified platforms
CPC B01J19/0046, C12Q1/6874, G01N35/1002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of immunotherapeutics for cancer treatment
ImmunotherapyUS$101.22mSeries C · Oct 2022
41LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 20
- Recorded funding
- US$101.22m · Series C · Oct 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$101.22m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Roy MauteCo-Founder
- Highest education
- Doctorates in genetics · Columbia University In The City Of New York
Investors · 4
AlexandriaFund
- Stanford University Presidential Venture FundFund
Team & hiring signals
LinkedIn headcount4111-50
LinkedIn followers5,621
Recent company signals
- Launch Launched PHST677 (advanced bispecific ADC targeting CDH1 (E-cadherin) and Nectin-4)
Technology
- Cloudflare
Zendesk
Webflow- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic solutions for acute cardiovascular symptoms
Cardiac and vascular disordersUS$79.70mSeries C · Oct 2020
11-45% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 30 (previous snapshot 55)
- Recorded funding
- US$79.70m · Series C · Oct 2020
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$79.70m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Narsi RangachariCo-Founder, COO (Consulting)
Investors · 7
- DeerfieldFund
HealthcapFund
InnovivaFund
MorningsideFund
- MorningsideFund
Team & hiring signals
LinkedIn headcount1111-50
LinkedIn followers3,699
Technology
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of device to treat urinary obstruction related to BPH
Genitourinary disordersUS$79.49mSeries C · Nov 2024
42+14% 12 mo to Dec 2020LinkedIn · Jul 2026
E-commerce - product / Physical commerce
12 yr2014
0none in 3 months · last posted Mar 2026
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 25 (previous snapshot 32)
- Recorded funding
- US$79.49m · Series C · Nov 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutics, Urinary obstruction
Funding over time
US$79.49m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Shreya Mehtaex-Co-Founder & CEO
- Highest education
- Bioengineering · University of Pittsburgh
Investors · 10
Astia AngelsFund- F-Prime CapitalFund
Golden SeedsFund
InvusFund
ShangBay CapitalFund
Y CombinatorFund- Cook MedicalFund
CloudstoneFund
Team & hiring signals
LinkedIn headcount4211-50
LinkedIn followers4,259
Earlier recorded team252020, a different source
Open roles2of 3 tracked · last posted Mar 2026
Recent company signals
- Launch Launched Zenflow Spring® Implant and Delivery System (Urology / FIT)
Patents
Patent filings69
Focus: Precise implantation and imaging devices for prostatic urethra treatments
CPC A61F2/966, A61F2/042, A61F2/885Mobile apps
- Zenflow AppBooks & Reference · 13 installs · updated 2023-12-06
Technology
- Cloudflare
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of precision therapeutics for immune-mediated diseases
ImmunologyUS$64.00mSeries C · Jun 2022
7+31% 12 mo to Dec 2022LinkedIn · Jul 2026
Fee-for-service
8 yr2018
0none in 3 months
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 21
- Recorded funding
- US$64.00m · Series C · Jun 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$64.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Jason SpringsCo-Founder &CEO
- Highest education
- Master's of business administration in entrepreneurship · Cornell Johnson Graduate School Of Management
Leonardo TeixeiraCo-Founder
- Highest education
- Doctor of Philosophy · Cornell University
Diego ReyCo-Founder
- Highest education
- Doctor of Philosophy, Biomedical Engineering · Cornell University
Investors · 10
Alix VenturesFund
Humboldt FundFund
MayfieldFund
Team & hiring signals
LinkedIn headcount711-50
LinkedIn followers2,546
Earlier recorded team212022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of Immunotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infections
OncologyUS$60.00mSeries A · Jun 2022
12recorded
Fee-for-service
5 yr2021
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 12
- Recorded funding
- US$60.00m · Series A · Jun 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Viral, Hepatitis
Leadership · 1
Ben BuelowCEO
- Highest education
- MD, Immunology · University of Washington
Investors · 2
SR OneFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a wearable sleep monitoring system
Wearable technologyUS$55.72mSeries C · Jan 2024
69-18% vs previous recordLinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months
ConsumerHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 50 (previous snapshot 61)
- Recorded funding
- US$55.72m · Series C · Jan 2024
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Mind & body wellness, Sleep management, Devices, Health and wellness devices
Funding over time
US$55.72m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Pieter ErmersVP Research and Development & Founder
- Highest education
- Electronics · Fontys University
Hartmut SchneiderCo-Founder & CMO
Investors · 10
+2 more
Team & hiring signals
LinkedIn headcount6911-50
LinkedIn followers16,618
Recent company signals
- Partnership Partnership with Somnoware Healthcare Systems
Technology
- Cloudflare
Salesforce- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of embryology diagnosis device for professionals
Women healthUS$49.20mSeries C · Apr 2025
45-41% vs previous recordLinkedIn · Jul 2026
Physical commerce
9 yr2017
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 41 (previous snapshot 70)
- Recorded funding
- US$49.20m · Series C · Apr 2025
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- In vitro diagnostic tests, Embryo viability
Funding over time
US$49.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Jose HorcajadasCo-Founder & Chief Scientific Officer
Santiago MunneCo-Founder & CIO
Martin VarsavskyCo-Founder & Chairman
- Highest education
- MBA · Columbia Business School
Investors · 6
Felicis VenturesFund- Google VenturesFund
Khosla VenturesFund
Octopus VenturesFund
- Marc BenioffAngel
Team & hiring signals
LinkedIn headcount4511-50
LinkedIn followers11,805
Recent company signals
- Leadership Hired a Finance Director
- Partnership Partnership with TekServis Ltd. ti.
Patents
Patent filings44
Focus: Automated microinjection and microfluidic IVF/embryo handling technologies
CPC B01L3/502715, G01N33/5005, A01N1/144Technology
- AWS
- React
- Cloudflare
- HubSpot
Amazon S3
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of POC ultrasound device to calculate bladder volume
Genitourinary disordersUS$44.00mPE · Nov 2015
112-7% 12 mo to Dec 2021recorded Dec 2021
E-commerce - product / Physical commerce
21 yr2005
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 112
- Recorded funding
- US$44.00m · PE · Nov 2015
- Founded
- 2005 · about 21 years old
- Stage
- Series B
- Focus
- Medical devices, Screening, Urinary bladder
Funding over time
US$44.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Stewart BartlettCo-Founder & COO
- Highest education
- Master's of business administration · Agsm @ Unsw Business School
Neil BartlettCo-Founder
Investors · 5
Brandon CapitalFund
BridgeLaneFund
KKRFund
PlayfordFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Therapeutics using polymers of hyaluronic acid for pain management.
Life sciences platforms and toolsUS$42.90mSeries C · Mar 2015
2-50% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
22 yr2004
0none in 3 months
ConsumerSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 7
- Recorded funding
- US$42.90m · Series C · Mar 2015
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Drugs, Pain, Research services, Diversified
Funding over time
US$42.90m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 2
David RenziCEO
Andrew CrockettCEO
- Highest education
- Master's of science · Ucl
Investors · 3
Alta PartnersFund
Vivo CapitalFund
Team & hiring signals
LinkedIn headcount2
LinkedIn followers103
Earlier recorded team72022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of the omic data platform for researchers
Life sciences techUS$42.71mSeries A · Mar 2023
128LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$42.71m · Series A · Mar 2023
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Funding over time
US$42.71m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mostafa RonaghiCo-Founder
- Highest education
- Doctor of Philosophy · KTH
Team & hiring signals
LinkedIn headcount12851-200
LinkedIn followers6,032
Patents
Patent filings77
Focus: Microfluidic cell analysis, sorting, and multiplex assay platforms for engineered cell screening
CPC B01L3/502715, C12Q1/6806, G01N33/54386Technology
- AWS
- Cloudflare
- Salesforce
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing non-opioid pain management solutions for acute and chronic pain
NeurologyUS$40.84mSeries B · Apr 2023
8-38% vs previous recordrecorded
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8 (previous snapshot 13)
- Recorded funding
- US$40.84m · Series B · Apr 2023
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs, Pain, Diversified
Funding over time
US$40.84m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Joseph PergolizziCo-Founder
Patents
Patent filings5
Focus: Topical analgesic and anti-inflammatory pharmaceutical formulations
CPC A61K31/415, C07D231/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics to address IVF failure and recurrent pregnancy loss
Women healthUS$37.81mSeries B · Oct 2015
2LinkedIn · Jul 2026
Fee-for-service
19 yr2007
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$37.81m · Series B · Oct 2015
- Founded
- 2007 · about 19 years old
- Stage
- Series B
- Focus
- Drugs, Reproductive diseases
Funding over time
US$37.81m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Chris McClainEx-Co-Founder
- Highest education
- Leadership · Center For Creative Leadership
Investors · 5
- Novo HoldingsFund
- Vivo CapitalFund
Team & hiring signals
LinkedIn headcount211-50
LinkedIn followers61
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics to treat retinal diseases
OphthalmologyUS$35.84mSeries B · Mar 2016
135+20% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months · last posted Jan 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 112 (previous snapshot 111)
- Recorded funding
- US$35.84m · Series B · Mar 2016
- Founded
- 2009 · about 17 years old
- Stage
- Public
- Focus
- Medical devices, Therapy, Retinal disorders
Funding over time
US$35.84m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Victor PerlrothChairman and CEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Team & hiring signals
LinkedIn headcount13551-200
LinkedIn followers14,700
Earlier recorded team1122022, a different source
Open roles1of 3 tracked · last posted Jan 2026
Patents
Patent filings211
Focus: Antibody‑drug conjugates and protein therapeutics targeting cytokines and ocular disease.
CPC C07K16/22, C07K16/248, C08F230/02Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Topical antifungal treatments
Infectious diseasesUS$31.52mSeries B · Jun 2013
11recorded
E-commerce - product / Physical commerce
18 yr2008
—No postings tracked
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 11
- Recorded funding
- US$31.52m · Series B · Jun 2013
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Drugs, Fungal
Investors · 3
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapies for treating neurological disorders
NeurologyUS$30.76mSeries A · Oct 2025
5+0% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 2
- Recorded funding
- US$30.76m · Series A · Oct 2025
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$30.76m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Brendan MagrabCEO
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers97
Earlier recorded team22022, a different source
Patents
Patent filings30
Focus: Prodrug and formulation technologies for intravenous anesthetic propofol delivery
CPC A61K31/661, A61K31/05, A61P25/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of silicon-based nanomachine chips
GenomicsUS$29.60mSeries A · Nov 2021
6+12% vs previous recordLinkedIn · Jul 2026
Subscription
10 yr2016
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48 (previous snapshot 43)
- Recorded funding
- US$29.60m · Series A · Nov 2021
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Enabling technologies, Technology platforms, Gene delivery, Actuators
Funding over time
US$29.60m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Greg SittersCo-Founder
- Highest education
- Macquarie Graduate School On Management
Steven BanerjeeCo-Founder & CEO
Anil NarasimhaCo-Founder & CSO
- Highest education
- Doctorates, Biology · Uc San Diego
Investors · 14
CRCM VenturesFund- DebiopharmFund
Good AI CapitalFund
Hike VenturesFund
MagnetarFund
NovartisFund
PEAK6Fund
Team & hiring signals
LinkedIn headcount611-50
LinkedIn followers2,096
Patents
Patent filings49
Focus: Patents concentrated in transport & manufacturing processes
CPC B01L3/502761, B81B1/002, G03F7/0035Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Radio frequency (RF) electrosurgical instruments for tissue fusion and cutting
Surgical instrumentsUS$25.00mSeries B · Jan 2008
10+133% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
21 yr2005
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 28 (previous snapshot 12)
- Recorded funding
- US$25.00m · Series B · Jan 2008
- Founded
- 2005 · about 21 years old
- Stage
- Series B
- Focus
- Cutting and ablating
Investors · 4
Bay City CapitalFund
Delphi VenturesFund
ONSET VenturesFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers702
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of AI-driven enzyme and targeted drug design for therapeutics
Life sciences techUS$25.00mSeed · Sep 2025
—Not available
Subscription
6 yr2020
—No postings tracked
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$25.00m · Seed · Sep 2025
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Ai based, Cheminformatics, Drug discovery, Lead discovery
Investors · 2
Overlap HoldingsFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for the treatment of inflammatory and rare diseases
PulmonologyUS$22.67mSeries A · Oct 2025
19+27% vs previous recordLinkedIn · Jul 2026
Subscription
8 yr2018
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 15)
- Recorded funding
- US$22.67m · Series A · Oct 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Inflammatory diseases, Diversified
Funding over time
US$22.67m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Ritu LalCo-Founder & CEO
Investors · 2
Clear VenturesFund- Y CombinatorFund
Team & hiring signals
LinkedIn headcount192-10
LinkedIn followers1,095
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
AI‑driven lab automation platform
Professional service robotsUS$21.50mSeries A · May 2021
15+18% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 55)
- Recorded funding
- US$21.50m · Series A · May 2021
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Tech enablers, Software, No code robotic programming, Machine intelligence systems
Investors · 3
- M12Fund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers5,125
Earlier recorded team262022, a different source
Recent company signals
- Launch Launched Tips (AI assistant for lab systems)
Patents
Patent filings97
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G06N20/00, G06N3/084, G16C20/50Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of protein sequencing technology using silicon photonics and machine learning
Life sciences platforms and toolsUS$20.00mSeries A · May 2026
—Not available
Subscription
5 yr2021
—No postings tracked
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$20.00m · Series A · May 2026
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Proteomics, Research services
Founders · 3
Jennifer DionneCo-Founder
- Highest education
- Bachelor's of Science (B.S.), Systems Science and Engineering; Physics · WashU
Jack HuCo-Founder
Nhat VuCo-Founder
Investors · 5
Analog DevicesFund
Future VenturesFund
NFXFund- Base4 CapitalFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Technology solutions for critical care patient management, promoting health and safety
PulmonologyUS$15.75mSeries B · Aug 2020
47+21% vs previous recordLinkedIn · Jul 2026
Subscription
15 yr2011
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 34 (previous snapshot 28)
- Recorded funding
- US$15.75m · Series B · Aug 2020
- Founded
- 2011 · about 15 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Chest physiotherapy and airway clearance
Funding over time
US$15.75m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Rafael SquitieriCo-Founder & CTO
- Highest education
- Doctor of medicine in medicine · Icahn School Of Medicine At Mount Sinai
Kim OrumchianCEO, Co-Founder
- Highest education
- Bachelor's in applied physics · Columbia Engineering
Team & hiring signals
LinkedIn headcount4711-50
LinkedIn followers1,422
Patents
Patent filings138
Focus: Therapeutic compression garments with inflatable perfusion and integrated power/monitoring systems
CPC A61G7/05776, A61F13/51474, A61F5/34Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Biotechnology company that employs protein engineering solutions
Life sciences techUS$15.64mSeed · Jan 2026
22LinkedIn · Jul 2026
Subscription
3 yr2023
0none in 3 months · last posted May 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$15.64m · Seed · Jan 2026
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Drug discovery, Proteomics, Research & development
Funding over time
US$15.64m across 3 disclosed equity rounds
Darker bars = larger roundsInvestors · 6
InventureFund
TesiFund
Voima VenturesFund
BalnordFund- DimerentFund
Team & hiring signals
LinkedIn headcount2211-50
LinkedIn followers2,560
Open roles1of 1 tracked · last posted May 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
AI-based business development tool for healthcare
Life sciences techUS$15.01mSeries A · Mar 2025
19+12% vs previous recordLinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 25)
- Recorded funding
- US$15.01m · Series A · Mar 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Provider, Administrative solutions, Business and market intelligence, Business intelligence
Funding over time
US$15.01m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Lana FengCo-Founder & CEO
- Highest education
- University Of California, San Diego - School Of Medicine
Greg KostelloCo-Founder & CTO
Investors · 9
Fusion FundFund
Human LongevityFund- ShangBay CapitalFund
The King's FundFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers3,254
Technology
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Biorisk management platform
Grc softwareUS$13.02mSeed · Apr 2021
46LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months · last posted Feb 2026
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48
- Recorded funding
- US$13.02m · Seed · Apr 2021
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Risk management, Integrated risk management, Grc solutions, Biorisk managment
Funding over time
US$13.02m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Charity DeanCo-Founder & CEO
- Highest education
- Tulane University
Investors · 3
Team & hiring signals
LinkedIn headcount4651-200
LinkedIn followers3,255
Open roles3of 6 tracked · last posted Feb 2026
Technology
- Cloudflare
- HubSpot
Firebase
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of software solutions and Q- pad for women's health monitoring & tracking
Healthcare booking platformsUS$12.42mSeries A · Oct 2020
16LinkedIn · Jul 2026
Subscription
12 yr2014
0none in 3 months
ConsumerSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 24
- Recorded funding
- US$12.42m · Series A · Oct 2020
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Medical devices, Monitoring, Fertility tracking, Pharmacies
Funding over time
US$12.42m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sara NaseriCo-Founder
Investors · 2
ByfoundersFund- Y CombinatorFund
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers5,266
Patents
Patent filings3
Focus: Automatic self-closing lid mechanisms for containers and packaging
CPC B65D90/623Mobile apps
- QvinHealth & Fitness · 1,532 installs · ★ 4.5 · updated 2026-04-28
- SamplesHealth & Fitness · 10 installs · updated 2026-04-10
Technology
- AWS
- React
- PHP
- MySQL
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of machine learning cell imaging platform for regenerative medicines
Cell therapyUS$12.00mSeed · May 2025
—Not available
Advertising / Commission on transaction
5 yr2021
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Advertising, Commission on transaction, E-commerce - service
- Team size
- Not available
- Recorded funding
- US$12.00m · Seed · May 2025
- Founded
- 2021 · about 5 years old
- Stage
- Seed
- Focus
- Diversified, Drugs, Imaging systems, Instruments
Investors · 11
AIX VenturesFund
AxialFund
BoxOne VenturesFund
DimensionFund
Village GlobalFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of gene therapies for musculoskeletal and joint diseases
OrthopedicsUS$10.50mSeries A · May 2022
4LinkedIn · Jul 2026
Fee-for-service
9 yr2017
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 6 (previous snapshot 4)
- Recorded funding
- US$10.50m · Series A · May 2022
- Founded
- 2017 · about 9 years old
- Stage
- Series A
- Focus
- Drugs, Osteoarthritis
Founders · 1
Thomas ChalbergFounder/CEO
- Highest education
- Master's of business administration in biotechnology · University Of California, Berkeley
Investors · 3
DeepWork CapitalFund- Polymerase CapitalFund
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers874
Patents
Patent filings9
Focus: Patents concentrated in health & consumer products
CPC A61K38/2006, C12N15/86, A61K47/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of immune-competent human-derived models for drug development
Life sciences platforms and toolsUS$7.90mSeries A · Dec 2021
2-11% vs previous recordLinkedIn · Jul 2026
Physical commerce
5 yr2021
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 8 (previous snapshot 9)
- Recorded funding
- US$7.90m · Series A · Dec 2021
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research assays, Drug discovery, Organoid models
Founders · 3
Calvin KuoCo-Founder
Mark DavisCo-Founder
Adam MargolinCo-Founder & CEO
- Highest education
- Doctor of Philosophy · Columbia University
Investors · 3
- AlexandriaFund
- Khosla VenturesFund
Team & hiring signals
LinkedIn headcount22-10
LinkedIn followers844
Earlier recorded team82022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Small molecule drug conjugates to treat cancer
OncologyUS$7.50mSeries A · Oct 2019
3LinkedIn · Jul 2026
Subscription
12 yr2014
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 3
- Recorded funding
- US$7.50m · Series A · Oct 2019
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$7.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Steven EverettFounder, President & CEO
Investors · 2
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers280
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of cloud-based AI solution for the life sciences industry
Life sciences techUS$6.00mSeed · Mar 2022
13LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 17
- Recorded funding
- US$6.00m · Seed · Mar 2022
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Data analysis platforms
Founders · 2
Michelle WuCo-Founder & CEO
- Highest education
- Master's of Business Administration · Stanford Graduate School of Business
Qiang KouCo-Founder
- Highest education
- PhD · IUPUI
Investors · 3
- GSR VenturesFund
Team & hiring signals
LinkedIn headcount1311-50
LinkedIn followers2,435
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Proprietary delivery technology to send large molecules through tissue structures
Life sciences platforms and toolsUS$5.00mSeries A · Feb 2017
5recorded
Physical commerce
10 yr2016
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 5
- Recorded funding
- US$5.00m · Series A · Feb 2017
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Diversified, Research services
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
AI-powered solutions to simplify workflows in pharmaceutical research
Life sciences techUS$4.00mSeed · Aug 2025
24LinkedIn · Jul 2026
Subscription
2 yr2024
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.00m · Seed · Aug 2025
- Founded
- 2024 · about 2 years old
- Stage
- Seed
- Focus
- Clinical data analysis, Drug informatics, Research & development
Founders · 3
Harshit GuptaCo-Founder
Jason ParkCo-Founder & CPO
Minseok BaeCo-Founder & CEO
Investors · 3
- SK NetworksFund
- Aidan GomezAngel
- Illia PolosukhinAngel
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers31,475
Recent company signals
- Leadership Hired a Head of Business
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Measures blood pressure-related health condition
Cardiac and vascular disordersUS$4.00mSeries A · Aug 2015
3LinkedIn · Jul 2026
Fee-for-service
13 yr2013
0none in 3 months
ConsumerSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$4.00m · Series A · Aug 2015
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Medical devices, Monitoring devices, Vital signs, Home based
Founders · 2
Naama StauberCo-Founder
Daniel Wei-Chen HongCo-Founder
Investors · 1
Jing Di Min Mobile Internet Technology CoFund
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers203
Technology
- AWS
- PHP
Bootstrap- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Tools for innovations in oncology and cell therapy research
Life sciences platforms and toolsUS$3.93mSeries A · Apr 2015
12recorded
Subscription
17 yr2009
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12
- Recorded funding
- US$3.93m · Series A · Apr 2015
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- Research services, Diversified
Funding over time
US$3.93m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Caleb Branson BellCo-Founder & CTO
Dan BellCo-Founder & CFO
Ken HarrisCo-Founder & CEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of microbiome therapeutics to treat inflammatory diseases
Microbiome therapeuticsUS$3.00mSeed · Dec 2023
2LinkedIn · Jul 2026
Subscription
6 yr2020
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 7
- Recorded funding
- US$3.00m · Seed · Dec 2023
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Drugs, Inflammatory diseases
Investors · 3
Team & hiring signals
LinkedIn headcount22-10
LinkedIn followers793
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Biotech innovating diagnostics and imaging products for life science research
Imaging diagnosticsUS$2.00mSeed · Aug 2014
8+25% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce
13 yr2013
—No postings tracked
Social impactSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 5 (previous snapshot 12)
- Recorded funding
- US$2.00m · Seed · Aug 2014
- Founded
- 2013 · about 13 years old
- Stage
- Seed
- Focus
- Microscopy
Founders · 1
Hongjie DaiFounder and Scientific Advisor
Investors · 1
- StartXFund
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers464
Earlier recorded team52022, a different source
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
AI-powered platform for drug screening and development
Life sciences techUS$1.00mSeries A · Apr 2024
19LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$1.00m · Series A · Apr 2024
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Founders · 1
Christopher MoxhamFounder & CEO
- Highest education
- Doctor of Philosophy, Pharmacology · Stony Brook University
Investors · 2
BlueYardFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers3,926
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of DNA sequencing based personalised medicine
GenomicsUS$650kSeed · Jul 2020
8+29% vs previous recordLinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 9 (previous snapshot 7)
- Recorded funding
- US$650k · Seed · Jul 2020
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$650k across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Daniel UribeCo-Founder & CEO
- Highest education
- Communication · General Assembly
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers1,127
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
50 of 140 companies shown here · the full list is on Radar
Fliar Radar
Explore all 140 life sciences companies in Palo Alto on Radar
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Palo Alto on Radar- Every company, not just 50All 140 life sciences companies in Palo Alto, filterable by stage, funding, team size, revenue model and age.
- Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
- Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
- Save and exportBuild lists, compare companies side by side and export them from your Radar account.
Explore life sciences companies in Palo Alto by what you are looking for
Find top life sciences companies in Palo Alto across research tools, oncology and genomics. Explore life sciences startups in Palo Alto alongside public companies.
7 ways to explore life sciences in Palo Alto
Life sciences technology companiesOncology companiesGenomics companiesNeurology and cardiac health companiesLife sciences startups in Palo AltoLife sciences companies hiring in Palo Alto
Life sciences technology companies
Technology platforms and tools for life sciences research.
- MedableSee in list
Provider of a cloud based clinical trail management tool for researchers
Life sciences tech - AntheiaSee in list
Genetically engineered yeast cells to produce medicinal products
Genomics - InceptiveSee in list
AI-based RNA molecular modeling tool for the vaccine
Life sciences tech - Centrillion TechnologiesSee in list
Developer of DNA chips and molecular assays
Genomics - CarbylanSee in list
Therapeutics using polymers of hyaluronic acid for pain management.
Life sciences platforms and tools
51 companies in Palo AltoAll 33 life sciences tech companies in Palo Alto →
Oncology companies
Companies developing cancer diagnostics and therapies.
- TrueBindingSee in list
Developer of biotherapeutic solutions for cancer treatment
Oncology - Exai BioSee in list
Developer of RNA biomarkers and AI platform for cancer detection
Oncology - PheastSee in list
Developer of immunotherapeutics for cancer treatment
Immunotherapy - MaveriX OncologySee in list
Small molecule drug conjugates to treat cancer
Oncology 
TelikDiscovering and developing small molecule drugs for the treatment of cancer
Oncology
19 companies in Palo AltoAll 2,665 oncology companies in United States →
Genomics companies
Genomics and sequencing companies for life sciences.
- AntheiaSee in list
Genetically engineered yeast cells to produce medicinal products
Genomics - Exai BioSee in list
Developer of RNA biomarkers and AI platform for cancer detection
Oncology - Centrillion TechnologiesSee in list
Developer of DNA chips and molecular assays
Genomics - GenoBankSee in list
Provider of DNA sequencing based personalised medicine
Genomics 
System BioInnovative tools and services for molecular and cell biology research
Life sciences tech
21 companies in Palo AltoAll 2,583 genomics companies in United States →
Neurology and cardiac health companies
Companies focused on neurological and cardiovascular health.
- EpalexSee in list
Developer of therapies for treating neurological disorders
Neurology 
CoA TherapeuticsDeveloping novel therapies for Coenzyme A genetic disorders
Neurology
NeuvivoDeveloper of therapeutics for the treatment of neurodegenerative diseases
Neurology
Instant Heart RateInstant Heart Rate: Monitor heart health easily with your phone
Wearable technology
122 LabsProvider of smart devices for blood pressure & heart rate monitoring
Wearable technology
29 companies in Palo AltoAll 1,624 neurology companies in United States →
Life sciences startups in Palo Alto
Recently founded life sciences companies in Palo Alto.
- OrsoBioSee in list
Developer of therapeutics for multiple metabolic diseases
Diabetes - Bitterroot BioSee in list
Immunotherapy to develop and deliver medicines for cardiovascular disease
Cardiac and vascular disorders - InceptiveSee in list
AI-based RNA molecular modeling tool for the vaccine
Life sciences tech - Ancora BiotechSee in list
Developer of Immunotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infections
Oncology - PumpkinseedSee in list
Developer of protein sequencing technology using silicon photonics and machine learning
Life sciences platforms and tools
25 companies in Palo Alto
Life sciences companies hiring in Palo Alto
Life sciences companies in Palo Alto with hiring activity.
- MedableSee in list
Provider of a cloud based clinical trail management tool for researchers
Life sciences tech - AntheiaSee in list
Genetically engineered yeast cells to produce medicinal products
Genomics - Bitterroot BioSee in list
Immunotherapy to develop and deliver medicines for cardiovascular disease
Cardiac and vascular disorders - Exai BioSee in list
Developer of RNA biomarkers and AI platform for cancer detection
Oncology - InceptiveSee in list
AI-based RNA molecular modeling tool for the vaccine
Life sciences tech
14 companies in Palo Alto
Public life sciences companies in Palo Alto
Publicly listed life sciences companies in Palo Alto.
- AffymaxSee in list
Drug for treatment of chronic kidney disease
Metabolic diseases - CarbylanSee in list
Therapeutics using polymers of hyaluronic acid for pain management.
Life sciences platforms and tools - Kodiak SciencesSee in list
Developer of therapeutics to treat retinal diseases
Ophthalmology 
OmniAbTherapeutic antibody discovery company providing diverse antibody repertoires and cutting-edge screening technologies
Life sciences platforms and tools
Scilex HoldingDeveloper of non-opioid therapies for acute and chronic pain
Drug delivery
9 companies in Palo Alto
Mobile reach
Top 4 life sciences apps from Palo Alto
The most-installed Android apps published by life sciences companies headquartered in Palo Alto — 31.3M installs between them. 4 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
1 of 4
Installs31.3M
Rating3.71311K ratings
Installs, year on year+0%
Last updatedApr 2026
Legal entityBodymatter, Inc.declared on Google Play
Installs4K
Rating4.013 ratings
Last updatedJun 2026
Legal entityMedable Inc.declared on Google Play
Installs2K
Rating4.5414 ratings
Last updatedApr 2026
Legal entityQurasense, Inc.declared on Google Play
Installs13
Rating—
Last updatedDec 2023
Legal entityPlum Flower Software LLCdeclared on Google Play
For investors and data teams
Put this intelligence into your own tools
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
Capital & corporate activity
Life sciences funding and M&A across the United States
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Palo Alto compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months360
US$13.54bn
equity rounds, last 24 months1232
US$37.38bn
raised over five yearsUS$157.58bn
5,603 rounds in the United States
M&A deals, the United States1640
last 24 months
Capital by year
amount roundsEquity funding into life sciences in the United States
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
The funding ladder · five years
Rounds and typical cheque by stage
AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years
Most-funded sub-sectors
OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Palo Alto in context
Palo Alto’s share of the United States’s life sciences funding
Equity rounds over the last five years, 204 life sciences companies in Palo Alto among 27,407 in the United States.
Corporate activity · last 24 months
M&A in the United States
1361Acquisition
247Merger
13Takeover
Most active acquirers
- Eli lilly18
- Merck & Co. Inc.16
- Novartis15
- Roche AG15
- Boston scientific14
Most acquired or merged
- Bluebird bio14
- Teleflex11
- Staar surgical company11
- Exact sciences9
- Terns pharmaceuticals8
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United States AI Industry Landscape of Palo Alto Enterprise Infrastructure Industry Landscape of Palo AltoIndustry landscape report
Life Sciences Industry Landscape of the United States
The financials above are one chapter. The full life sciences landscape of Palo Alto maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
- Market map of every sub-sector
- Funding & company formation by year
- Revenue, profit & financial strength
- Digital footprint: traffic, apps, releases
- Hiring, skills & pay
- Founders & leaders
- News & sentiment
- Where demand runs ahead of supply
Life sciences funding in Palo Alto
52 life sciences companies in Palo Alto have recorded equity funding, US$2.99bn in total. Totals and round dates describe the historical record; they are not current valuations.
Most funded
Largest recorded equity totals, with the latest recorded round.
Life sciences techProvider of a cloud based clinical trail management tool for researchers
Recorded equity fundingUS$518.45mSeries D · Oct 2021
Founders · 3
James SasCo-Founder
Tim SmithCo-Founder, CTO
Michelle LongmireCo-Founder & CEO
GenomicsGenetically engineered yeast cells to produce medicinal products
Recorded equity fundingUS$176.37mSeries C · Jan 2026
Founders · 2
Christina SmolkeCo-Founder & CEO
Kristy HawkinsCo-Founder & CSO
OncologyDeveloper of biotherapeutic solutions for cancer treatment
Recorded equity fundingUS$169.85mSeries D · Sep 2022
Leadership · 1
Dongxu SunCEO
DiabetesDeveloper of therapeutics for multiple metabolic diseases
Recorded equity fundingUS$153.33mSeries B · Feb 2025
Founder · 1
Mani SubramanianFounder & CEO
Cardiac and vascular disordersImmunotherapy to develop and deliver medicines for cardiovascular disease
Recorded equity fundingUS$145.00mSeries A · Jun 2023
Founders · 3
Irving WeissmanCo-Founder
Lou LangeCo-Founder
Nicholas LeeperCo-Founder
OncologyDeveloper of RNA biomarkers and AI platform for cancer detection
Recorded equity fundingUS$138.15mSeries B · Oct 2022
Founders · 2
Babak AlipanahiCo-Founder & Chief Scientific Officer
Hani GoodarziCo-Founder
ImmunotherapyDeveloper of antibodies to target immune system and tumor microenvironment
Recorded equity fundingUS$138.00mSeries B · Jan 2023
Founder · 1
Charlene LiaoFounder & CEO
Metabolic diseasesDrug for treatment of chronic kidney disease
Recorded equity fundingUS$131.00mPE · Jul 2005
Founders
Details not available
Life sciences techAI-based RNA molecular modeling tool for the vaccine
Recorded equity fundingUS$120.00mSeries A · Sep 2023
Founder · 1
Jakob UszkoreitCo-Founder & CEO
Cardiac and vascular disordersDeveloper of medical devices for treating mitral valve regurgitation
Recorded equity fundingUS$115.00mSeries C · Mar 2026
Founder · 1
Jacques EssingerFounder & CEO
GenomicsDeveloper of DNA chips and molecular assays
Recorded equity fundingUS$103.30mSeries C · Jul 2018
Founder · 1
Wei ZhouFounder & CEO
ImmunotherapyDeveloper of immunotherapeutics for cancer treatment
Recorded equity fundingUS$101.22mSeries C · Oct 2022
Founder · 1
Roy MauteCo-Founder
Cardiac and vascular disordersDeveloper of therapeutic solutions for acute cardiovascular symptoms
Recorded equity fundingUS$79.70mSeries C · Oct 2020
Founder · 1
Narsi RangachariCo-Founder, COO (Consulting)
Genitourinary disordersDeveloper of device to treat urinary obstruction related to BPH
Recorded equity fundingUS$79.49mSeries C · Nov 2024
Founder · 1
Shreya Mehtaex-Co-Founder & CEO
ImmunologyDeveloper of precision therapeutics for immune-mediated diseases
Recorded equity fundingUS$64.00mSeries C · Jun 2022
Founders · 3
Jason SpringsCo-Founder &CEO
Leonardo TeixeiraCo-Founder
Diego ReyCo-Founder
OncologyDeveloper of Immunotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infections
Recorded equity fundingUS$60.00mSeries A · Jun 2022
Leadership · 1
Ben BuelowCEO
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 376
- Recorded funding
- US$518.45m · Series D · Oct 2021
- Founded
- 2012 · about 14 years old
- Stage
- Series D
- Focus
- Research & development, Clinical trials, Study implementation, Ctms and edc
Funding over time
US$518.45m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 3
James SasCo-Founder
Tim SmithCo-Founder, CTO
- Highest education
- Bachelor's · The University Of Texas At Austin
Michelle LongmireCo-Founder & CEO
- Highest education
- Stanford University School Of Medicine
Investors · 8
- BlackstoneFund
- GSR VenturesFund
- Obvious VenturesFund
- PPDFund
- WTIFund
Team & hiring signals
LinkedIn headcount341501-1,000
LinkedIn followers120,886
Earlier recorded team3762022, a different source
Open roles1of 3 tracked · last posted Nov 2025
Patents
Patent filings14
Focus: Digital health data integration, remote patient monitoring, and HIPAA compliance automation
CPC G16H50/20, G06Q10/0639, G16H80/00Mobile apps
- MedableMedical · 4,345 installs · ★ 4.0 · updated 2026-06-05
- ZEUS Study App (EX6018-4758)Medical · 3,456 installs · updated 2024-10-08
- P23-899 PatientMedical · 673 installs · updated 2025-03-10
Technology
- AWS
- React
- Nginx
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50 (previous snapshot 61)
- Recorded funding
- US$176.37m · Series C · Jan 2026
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- Applied genomics, Synthetic biology, Research services, Diversified
Funding over time
US$176.37m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Christina SmolkeCo-Founder & CEO
- Highest education
- Doctor of Philosophy · The University of California
Kristy HawkinsCo-Founder & CSO
Investors · 11
- EDBIFund
- EchoFund
- In-Q-TelFund
- S-Cubed CapitalFund
Team & hiring signals
LinkedIn headcount6651-200
LinkedIn followers9,936
Earlier recorded team502022, a different source
Open roles1of 7 tracked · last posted Jun 2026
- Hiring: Associate Director of Global Quality
Recent company signals
- Leadership Hired a VP of Drug Innovation and Managing Director
Patents
Patent filings82
Focus: Biotechnological production and optimization of opioid alkaloids (benzylisoquinoline and morphinan)
CPC C12N15/52, C12P17/182, C12P17/12Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 89
- Recorded funding
- US$169.85m · Series D · Sep 2022
- Founded
- 2015 · about 11 years old
- Stage
- Series D
- Focus
- Drugs, Diversified
Funding over time
US$169.85m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dongxu SunCEO
- Highest education
- Doctorates in philosophy · University Of Minnesota
Team & hiring signals
LinkedIn headcount3451-200
LinkedIn followers5,790
Earlier recorded team892021, a different source
Recent company signals
- Milestone 380 patients enrolled
- Milestone more than 50% patients recruited
Patents
Patent filings80
Focus: Therapeutic antibodies targeting Galectin‑3 and protein‑aggregation inhibition for disease treatment
CPC C07K16/2851, C07K16/2803, A61P31/14Technology
- Angular
- TypeScript
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10 (previous snapshot 9)
- Recorded funding
- US$153.33m · Series B · Feb 2025
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$153.33m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mani SubramanianFounder & CEO
- Highest education
- Doctor of Philosophy · University of Michigan
Investors · 7
- Ascenta CapitalFund
- Enavate SciencesFund
- LillyFund
- NuevaBioFund
Team & hiring signals
LinkedIn headcount1711-50
LinkedIn followers3,330
Patents
Patent filings45
Focus: Small-molecule LXR modulators and ACMSD inhibitors for dyslipidemia and metabolic disease therapy
CPC C07D409/04, C07C311/14, C07D409/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12
- Recorded funding
- US$145.00m · Series A · Jun 2023
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Drugs, Coronary artery diseases, Diversified, Immuno oncology
Founders · 3
Irving WeissmanCo-Founder
- Highest education
- Stanford University
Lou LangeCo-Founder
- Highest education
- Doctor of Philosophy · Harvard University
Nicholas LeeperCo-Founder
- Highest education
- The University of Chicago
Investors · 5
- DeerfieldFund
- Google VenturesFund
- Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers3,895
Earlier recorded team122022, a different source
Open roles0of 1 tracked · last posted Jun 2025
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 47 (previous snapshot 55)
- Recorded funding
- US$138.15m · Series B · Oct 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- In-vitro diagnostic tests, Diversified
Funding over time
US$138.15m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Babak AlipanahiCo-Founder & Chief Scientific Officer
- Highest education
- Computer Science · University of Waterloo
Hani GoodarziCo-Founder
Investors · 3
- Casdin CapitalFund
- S32Fund
Team & hiring signals
LinkedIn headcount2251-200
LinkedIn followers6,287
Open roles1of 1 tracked · last posted May 2026
Recent company signals
- Partnership Partnership with Deviation Capital
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 24 (previous snapshot 46)
- Recorded funding
- US$138.00m · Series B · Jan 2023
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$138.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Charlene LiaoFounder & CEO
- Highest education
- Northwestern University - Kellogg School Of Management
Investors · 12
- CLI VenturesFund
- Proxima VenturesFund
- Triwise CapitalFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers4,018
Earlier recorded team242022, a different source
Technology
- Cloudflare
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 72
- Recorded funding
- US$131.00m · PE · Jul 2005
- Founded
- 2001 · about 25 years old
- Stage
- Public
- Focus
- Drugs, Renal disorders
Funding over time
US$131.00m across 3 disclosed equity rounds
Darker bars = larger roundsInvestors · 4
- ApaxFund
- Credit SuisseFund
- MPM CapitalFund
- Bear Stearns CompaniesFund
Patents
Patent filings162
Focus: Erythropoietin receptor agonist peptides and PEGylated peptide drug delivery technologies
CPC C07K14/505, C07K14/001, A61K38/1816Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 35 (previous snapshot 30)
- Recorded funding
- US$120.00m · Series A · Sep 2023
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Vaccine discovery, Ai based
Funding over time
US$120.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jakob UszkoreitCo-Founder & CEO
- Highest education
- TU Berlin
Investors · 3
- Obvious VenturesFund
- NVIDIAFund
Team & hiring signals
LinkedIn headcount5511-50
LinkedIn followers10,432
Open roles0of 1 tracked · last posted Apr 2025
Recent company signals
- Partnership Partnership with Alnylam Pharmaceuticals
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 20
- Recorded funding
- US$115.00m · Series C · Mar 2026
- Founded
- 2010 · about 16 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Valvular diseases
Funding over time
US$115.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacques EssingerFounder & CEO
- Highest education
- PhD · EPFL
Investors · 8
- Decheng CapitalFund
- EarlybirdFund
- Endeavour VisionFund
- LuminationFund
- IDO InvestmentsFund
- DC Global VenturesFund
Team & hiring signals
LinkedIn headcount2511-50
LinkedIn followers745
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 36)
- Recorded funding
- US$103.30m · Series C · Jul 2018
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Research services, Genomics, Genomics services, Full service
Funding over time
US$86.80m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Wei ZhouFounder & CEO
- Highest education
- Leadership · Harvard Business School
Investors · 1
- WeDoctorFund
Team & hiring signals
Open roles4of 23 tracked · last posted May 2026
Patents
Patent filings6
Focus: High-throughput DNA sequencing reagents, microarray fabrication, and surface-modified platforms
CPC B01J19/0046, C12Q1/6874, G01N35/1002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 20
- Recorded funding
- US$101.22m · Series C · Oct 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$101.22m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Roy MauteCo-Founder
- Highest education
- Doctorates in genetics · Columbia University In The City Of New York
Investors · 4
- AlexandriaFund
- Stanford University Presidential Venture FundFund
Team & hiring signals
LinkedIn headcount4111-50
LinkedIn followers5,621
Recent company signals
- Launch Launched PHST677 (advanced bispecific ADC targeting CDH1 (E-cadherin) and Nectin-4)
Technology
- Cloudflare
- Zendesk
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 30 (previous snapshot 55)
- Recorded funding
- US$79.70m · Series C · Oct 2020
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$79.70m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Narsi RangachariCo-Founder, COO (Consulting)
Investors · 7
- DeerfieldFund
- HealthcapFund
- InnovivaFund
- MorningsideFund
- MorningsideFund
Team & hiring signals
LinkedIn headcount1111-50
LinkedIn followers3,699
Technology
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 25 (previous snapshot 32)
- Recorded funding
- US$79.49m · Series C · Nov 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutics, Urinary obstruction
Funding over time
US$79.49m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Shreya Mehtaex-Co-Founder & CEO
- Highest education
- Bioengineering · University of Pittsburgh
Investors · 10
- Astia AngelsFund
- F-Prime CapitalFund
- Golden SeedsFund
- InvusFund
- ShangBay CapitalFund
- Y CombinatorFund
- Cook MedicalFund
- CloudstoneFund
Team & hiring signals
LinkedIn headcount4211-50
LinkedIn followers4,259
Earlier recorded team252020, a different source
Open roles2of 3 tracked · last posted Mar 2026
Recent company signals
- Launch Launched Zenflow Spring® Implant and Delivery System (Urology / FIT)
Patents
Patent filings69
Focus: Precise implantation and imaging devices for prostatic urethra treatments
CPC A61F2/966, A61F2/042, A61F2/885Mobile apps
- Zenflow AppBooks & Reference · 13 installs · updated 2023-12-06
Technology
- Cloudflare
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 21
- Recorded funding
- US$64.00m · Series C · Jun 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$64.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Jason SpringsCo-Founder &CEO
- Highest education
- Master's of business administration in entrepreneurship · Cornell Johnson Graduate School Of Management
Leonardo TeixeiraCo-Founder
- Highest education
- Doctor of Philosophy · Cornell University
Diego ReyCo-Founder
- Highest education
- Doctor of Philosophy, Biomedical Engineering · Cornell University
Investors · 10
- Alix VenturesFund
- Humboldt FundFund
- MayfieldFund
Team & hiring signals
LinkedIn headcount711-50
LinkedIn followers2,546
Earlier recorded team212022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 12
- Recorded funding
- US$60.00m · Series A · Jun 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Viral, Hepatitis
Leadership · 1
Ben BuelowCEO
- Highest education
- MD, Immunology · University of Washington
Investors · 2
- SR OneFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Founders and momentum in Palo Alto
Meet the people behind life sciences companies in Palo Alto. 102 of 140 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Growing teams
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Surgical instrumentsRadio frequency (RF) electrosurgical instruments for tissue fusion and cutting
Team size28Up from 12 in the previous snapshot
Founders
Details not available
PulmonologyDeveloper of therapeutics for the treatment of inflammatory and rare diseases
Team size19Up from 15 in the previous snapshot
Founder · 1
Ritu LalCo-Founder & CEO
NeurologyDeveloping novel therapies for Coenzyme A genetic disorders
Team size11Up from 9 in the previous snapshot
Founders
Details not available
PulmonologyTechnology solutions for critical care patient management, promoting health and safety
Team size34Up from 28 in the previous snapshot
Founders · 2
Rafael SquitieriCo-Founder & CTO
Kim OrumchianCEO, Co-Founder
Life sciences techAI-based RNA molecular modeling tool for the vaccine
Team size35Up from 30 in the previous snapshot
Founder · 1
Jakob UszkoreitCo-Founder & CEO
Life sciences platforms and toolsDeveloper of technology for biomolecular detection
Team size57Up from 49 in the previous snapshot
Founders · 2
Hong TanCo-Founder & CEO
Robert ZukCo-Founder
Life sciences techAI-based business development tool for healthcare
Team size28Up from 25 in the previous snapshot
Founders · 2
Lana FengCo-Founder & CEO
Greg KostelloCo-Founder & CTO
GenomicsDeveloper of silicon-based nanomachine chips
Team size48Up from 43 in the previous snapshot
Founders · 3
Greg SittersCo-Founder
Steven BanerjeeCo-Founder & CEO
Anil NarasimhaCo-Founder & CSO
DiabetesDeveloper of therapeutics for multiple metabolic diseases
Team size10Up from 9 in the previous snapshot
Founder · 1
Mani SubramanianFounder & CEO
Life sciences techAI-based computational platform for drug discovery
Team size13Up from 12 in the previous snapshot
Founder · 1
Joseph WuCo-Founder
OphthalmologyDeveloper of therapeutics to treat retinal diseases
Team size112Up from 111 in the previous snapshot
Leadership · 1
Victor PerlrothChairman and CEO
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 28 (previous snapshot 12)
- Recorded funding
- US$25.00m · Series B · Jan 2008
- Founded
- 2005 · about 21 years old
- Stage
- Series B
- Focus
- Cutting and ablating
Investors · 4
- Bay City CapitalFund
- Delphi VenturesFund
- ONSET VenturesFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers702
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 15)
- Recorded funding
- US$22.67m · Series A · Oct 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Inflammatory diseases, Diversified
Funding over time
US$22.67m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Ritu LalCo-Founder & CEO
Investors · 2
- Clear VenturesFund
- Y CombinatorFund
Team & hiring signals
LinkedIn headcount192-10
LinkedIn followers1,095
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 11 (previous snapshot 9)
- Recorded funding
- None recorded
- Founded
- 2018 · about 8 years old
- Stage
- Unfunded
- Focus
- Drugs, Neurodegenerative, Diversified
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 34 (previous snapshot 28)
- Recorded funding
- US$15.75m · Series B · Aug 2020
- Founded
- 2011 · about 15 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Chest physiotherapy and airway clearance
Funding over time
US$15.75m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Rafael SquitieriCo-Founder & CTO
- Highest education
- Doctor of medicine in medicine · Icahn School Of Medicine At Mount Sinai
Kim OrumchianCEO, Co-Founder
- Highest education
- Bachelor's in applied physics · Columbia Engineering
Team & hiring signals
LinkedIn headcount4711-50
LinkedIn followers1,422
Patents
Patent filings138
Focus: Therapeutic compression garments with inflatable perfusion and integrated power/monitoring systems
CPC A61G7/05776, A61F13/51474, A61F5/34Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 35 (previous snapshot 30)
- Recorded funding
- US$120.00m · Series A · Sep 2023
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Vaccine discovery, Ai based
Funding over time
US$120.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jakob UszkoreitCo-Founder & CEO
- Highest education
- TU Berlin
Investors · 3
- Obvious VenturesFund
- NVIDIAFund
Team & hiring signals
LinkedIn headcount5511-50
LinkedIn followers10,432
Open roles0of 1 tracked · last posted Apr 2025
Recent company signals
- Partnership Partnership with Alnylam Pharmaceuticals
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 57 (previous snapshot 49)
- Recorded funding
- None recorded
- Founded
- 2020 · about 6 years old
- Stage
- Unfunded
- Focus
- Imaging systems, Instruments, Microscopy, Optical microscopy
Founders · 2
Hong TanCo-Founder & CEO
Robert ZukCo-Founder
Team & hiring signals
LinkedIn headcount7251-200
LinkedIn followers7,651
Open roles2of 5 tracked · last posted Apr 2026
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 25)
- Recorded funding
- US$15.01m · Series A · Mar 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Provider, Administrative solutions, Business and market intelligence, Business intelligence
Funding over time
US$15.01m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Lana FengCo-Founder & CEO
- Highest education
- University Of California, San Diego - School Of Medicine
Greg KostelloCo-Founder & CTO
Investors · 9
- Fusion FundFund
- Human LongevityFund
- ShangBay CapitalFund
- The King's FundFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers3,254
Technology
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48 (previous snapshot 43)
- Recorded funding
- US$29.60m · Series A · Nov 2021
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Enabling technologies, Technology platforms, Gene delivery, Actuators
Funding over time
US$29.60m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Greg SittersCo-Founder
- Highest education
- Macquarie Graduate School On Management
Steven BanerjeeCo-Founder & CEO
Anil NarasimhaCo-Founder & CSO
- Highest education
- Doctorates, Biology · Uc San Diego
Investors · 14
- CRCM VenturesFund
- DebiopharmFund
- Good AI CapitalFund
- Hike VenturesFund
- MagnetarFund
- NovartisFund
- PEAK6Fund
Team & hiring signals
LinkedIn headcount611-50
LinkedIn followers2,096
Patents
Patent filings49
Focus: Patents concentrated in transport & manufacturing processes
CPC B01L3/502761, B81B1/002, G03F7/0035Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10 (previous snapshot 9)
- Recorded funding
- US$153.33m · Series B · Feb 2025
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$153.33m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mani SubramanianFounder & CEO
- Highest education
- Doctor of Philosophy · University of Michigan
Investors · 7
- Ascenta CapitalFund
- Enavate SciencesFund
- LillyFund
- NuevaBioFund
Team & hiring signals
LinkedIn headcount1711-50
LinkedIn followers3,330
Patents
Patent filings45
Focus: Small-molecule LXR modulators and ACMSD inhibitors for dyslipidemia and metabolic disease therapy
CPC C07D409/04, C07C311/14, C07D409/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 12)
- Recorded funding
- None recorded
- Founded
- 2021 · about 5 years old
- Stage
- Funding Raised
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Founders · 1
Joseph WuCo-Founder
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers4,441
Recent company signals
- Partnership Partnership with Intel Corp.
Technology
- React
- Java
- PHP
- MySQL
- Nginx
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 112 (previous snapshot 111)
- Recorded funding
- US$35.84m · Series B · Mar 2016
- Founded
- 2009 · about 17 years old
- Stage
- Public
- Focus
- Medical devices, Therapy, Retinal disorders
Funding over time
US$35.84m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Victor PerlrothChairman and CEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Team & hiring signals
LinkedIn headcount13551-200
LinkedIn followers14,700
Earlier recorded team1122022, a different source
Open roles1of 3 tracked · last posted Jan 2026
Patents
Patent filings211
Focus: Antibody‑drug conjugates and protein therapeutics targeting cytokines and ocular disease.
CPC C07K16/22, C07K16/248, C08F230/02Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Women-founded
Life sciences companies in Palo Alto with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
Life sciences techProvider of a cloud based clinical trail management tool for researchers
Revenue modelSubscription
Founders · 3
James SasCo-Founder
Tim SmithCo-Founder, CTO
Michelle LongmireCo-Founder & CEO
GenomicsGenetically engineered yeast cells to produce medicinal products
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Christina SmolkeCo-Founder & CEO
Kristy HawkinsCo-Founder & CSO
Grc softwareBiorisk management platform
Revenue modelSubscription
Founder · 1
Charity DeanCo-Founder & CEO
Life sciences techAI-based business development tool for healthcare
Revenue modelSubscription
Founders · 2
Lana FengCo-Founder & CEO
Greg KostelloCo-Founder & CTO
Professional service robotsAI‑driven lab automation platform
Revenue modelSubscription
Founders
Details not available
Genitourinary disordersDeveloper of device to treat urinary obstruction related to BPH
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Shreya Mehtaex-Co-Founder & CEO
ImmunotherapyDeveloper of antibodies to target immune system and tumor microenvironment
Revenue modelFee-for-service
Founder · 1
Charlene LiaoFounder & CEO
Healthcare booking platformsProvider of software solutions and Q- pad for women's health monitoring & tracking
Revenue modelSubscription
Founder · 1
Sara NaseriCo-Founder
Life sciences techProvider of cloud-based AI solution for the life sciences industry
Revenue modelSubscription
Founders · 2
Michelle WuCo-Founder & CEO
Qiang KouCo-Founder
NeurologyDeveloping non-opioid pain management solutions for acute and chronic pain
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Joseph PergolizziCo-Founder
GenomicsDeveloper of PCR platform for true quantitation with multiplexing capabilities
Revenue modelSubscription
Founders · 3
Christina FCo-Founder
Stephen FodorCo-Founder & CEO
Ari ChaneyCo-Founder
Life sciences techAI-based computational platform for drug discovery
Revenue modelSubscription
Founder · 1
Joseph WuCo-Founder
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 376
- Recorded funding
- US$518.45m · Series D · Oct 2021
- Founded
- 2012 · about 14 years old
- Stage
- Series D
- Focus
- Research & development, Clinical trials, Study implementation, Ctms and edc
Funding over time
US$518.45m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 3
James SasCo-Founder
Tim SmithCo-Founder, CTO
- Highest education
- Bachelor's · The University Of Texas At Austin
Michelle LongmireCo-Founder & CEO
- Highest education
- Stanford University School Of Medicine
Investors · 8
- BlackstoneFund
- GSR VenturesFund
- Obvious VenturesFund
- PPDFund
- WTIFund
Team & hiring signals
LinkedIn headcount341501-1,000
LinkedIn followers120,886
Earlier recorded team3762022, a different source
Open roles1of 3 tracked · last posted Nov 2025
Patents
Patent filings14
Focus: Digital health data integration, remote patient monitoring, and HIPAA compliance automation
CPC G16H50/20, G06Q10/0639, G16H80/00Mobile apps
- MedableMedical · 4,345 installs · ★ 4.0 · updated 2026-06-05
- ZEUS Study App (EX6018-4758)Medical · 3,456 installs · updated 2024-10-08
- P23-899 PatientMedical · 673 installs · updated 2025-03-10
Technology
- AWS
- React
- Nginx
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50 (previous snapshot 61)
- Recorded funding
- US$176.37m · Series C · Jan 2026
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- Applied genomics, Synthetic biology, Research services, Diversified
Funding over time
US$176.37m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Christina SmolkeCo-Founder & CEO
- Highest education
- Doctor of Philosophy · The University of California
Kristy HawkinsCo-Founder & CSO
Investors · 11
- EDBIFund
- EchoFund
- In-Q-TelFund
- S-Cubed CapitalFund
Team & hiring signals
LinkedIn headcount6651-200
LinkedIn followers9,936
Earlier recorded team502022, a different source
Open roles1of 7 tracked · last posted Jun 2026
- Hiring: Associate Director of Global Quality
Recent company signals
- Leadership Hired a VP of Drug Innovation and Managing Director
Patents
Patent filings82
Focus: Biotechnological production and optimization of opioid alkaloids (benzylisoquinoline and morphinan)
CPC C12N15/52, C12P17/182, C12P17/12Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48
- Recorded funding
- US$13.02m · Seed · Apr 2021
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Risk management, Integrated risk management, Grc solutions, Biorisk managment
Funding over time
US$13.02m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Charity DeanCo-Founder & CEO
- Highest education
- Tulane University
Investors · 3
Team & hiring signals
LinkedIn headcount4651-200
LinkedIn followers3,255
Open roles3of 6 tracked · last posted Feb 2026
Technology
- Cloudflare
- HubSpot
- Firebase
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 25)
- Recorded funding
- US$15.01m · Series A · Mar 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Provider, Administrative solutions, Business and market intelligence, Business intelligence
Funding over time
US$15.01m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Lana FengCo-Founder & CEO
- Highest education
- University Of California, San Diego - School Of Medicine
Greg KostelloCo-Founder & CTO
Investors · 9
- Fusion FundFund
- Human LongevityFund
- ShangBay CapitalFund
- The King's FundFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers3,254
Technology
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 55)
- Recorded funding
- US$21.50m · Series A · May 2021
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Tech enablers, Software, No code robotic programming, Machine intelligence systems
Investors · 3
- M12Fund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers5,125
Earlier recorded team262022, a different source
Recent company signals
- Launch Launched Tips (AI assistant for lab systems)
Patents
Patent filings97
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G06N20/00, G06N3/084, G16C20/50Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 25 (previous snapshot 32)
- Recorded funding
- US$79.49m · Series C · Nov 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutics, Urinary obstruction
Funding over time
US$79.49m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Shreya Mehtaex-Co-Founder & CEO
- Highest education
- Bioengineering · University of Pittsburgh
Investors · 10
- Astia AngelsFund
- F-Prime CapitalFund
- Golden SeedsFund
- InvusFund
- ShangBay CapitalFund
- Y CombinatorFund
- Cook MedicalFund
- CloudstoneFund
Team & hiring signals
LinkedIn headcount4211-50
LinkedIn followers4,259
Earlier recorded team252020, a different source
Open roles2of 3 tracked · last posted Mar 2026
Recent company signals
- Launch Launched Zenflow Spring® Implant and Delivery System (Urology / FIT)
Patents
Patent filings69
Focus: Precise implantation and imaging devices for prostatic urethra treatments
CPC A61F2/966, A61F2/042, A61F2/885Mobile apps
- Zenflow AppBooks & Reference · 13 installs · updated 2023-12-06
Technology
- Cloudflare
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 24 (previous snapshot 46)
- Recorded funding
- US$138.00m · Series B · Jan 2023
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$138.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Charlene LiaoFounder & CEO
- Highest education
- Northwestern University - Kellogg School Of Management
Investors · 12
- CLI VenturesFund
- Proxima VenturesFund
- Triwise CapitalFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers4,018
Earlier recorded team242022, a different source
Technology
- Cloudflare
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 24
- Recorded funding
- US$12.42m · Series A · Oct 2020
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Medical devices, Monitoring, Fertility tracking, Pharmacies
Funding over time
US$12.42m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sara NaseriCo-Founder
Investors · 2
- ByfoundersFund
- Y CombinatorFund
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers5,266
Patents
Patent filings3
Focus: Automatic self-closing lid mechanisms for containers and packaging
CPC B65D90/623Mobile apps
- QvinHealth & Fitness · 1,532 installs · ★ 4.5 · updated 2026-04-28
- SamplesHealth & Fitness · 10 installs · updated 2026-04-10
Technology
- AWS
- React
- PHP
- MySQL
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 17
- Recorded funding
- US$6.00m · Seed · Mar 2022
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Data analysis platforms
Founders · 2
Michelle WuCo-Founder & CEO
- Highest education
- Master's of Business Administration · Stanford Graduate School of Business
Qiang KouCo-Founder
- Highest education
- PhD · IUPUI
Investors · 3
- GSR VenturesFund
Team & hiring signals
LinkedIn headcount1311-50
LinkedIn followers2,435
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8 (previous snapshot 13)
- Recorded funding
- US$40.84m · Series B · Apr 2023
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs, Pain, Diversified
Funding over time
US$40.84m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Joseph PergolizziCo-Founder
Patents
Patent filings5
Focus: Topical analgesic and anti-inflammatory pharmaceutical formulations
CPC A61K31/415, C07D231/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15
- Recorded funding
- None recorded
- Founded
- 2019 · about 7 years old
- Stage
- Funding Raised
- Focus
- Instruments, Genomics, Pcr, Digital pcr
Founders · 3
Christina FCo-Founder
Stephen FodorCo-Founder & CEO
Ari ChaneyCo-Founder
Team & hiring signals
LinkedIn headcount4811-50
LinkedIn followers3,140
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 12)
- Recorded funding
- None recorded
- Founded
- 2021 · about 5 years old
- Stage
- Funding Raised
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Founders · 1
Joseph WuCo-Founder
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers4,441
Recent company signals
- Partnership Partnership with Intel Corp.
Technology
- React
- Java
- PHP
- MySQL
- Nginx
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Recently founded
Life sciences companies in Palo Alto founded in the last four years, newest first.
Life sciences techAI-powered solutions to simplify workflows in pharmaceutical research
Founded2024Seed
Founders · 3
Harshit GuptaCo-Founder
Jason ParkCo-Founder & CPO
Minseok BaeCo-Founder & CEO
Generative aiDeveloper of AI-driven models for biological research and drug discovery
Founded2024Unfunded
Founders · 6
Ziv Bar-JosephCo-Founder & Chief Scientific Officer
Emma LundbergCo-Founder
Eric XingCo-Founder
Le SongCo-Founder & CTO
David BakerCo-Founder
Fred HuCo-Founder & CEO
OphthalmologyDeveloper of therapeutics for retinal disorders
Founded2024Late Stage
Founders · 4
Srinivas AkkarajuCo-Founder & Director
Napoleone FerraraCo-Founder
Samir PatelCo-Founder
Mike DybbsCo-Founder & Director
NeurologyTrainHealth – Neurological rehabilitation reimagined
Founded2024Unfunded
Founders
Details not available
Life sciences techBiotechnology company that employs protein engineering solutions
Founded2023Seed
Founders
Details not available
Life sciences techAI-driven digital pathology company for diagnostics and research
Founded2023Unfunded
Founders · 2
Webster LincolnCo-Founder & CEO
Inema OrukariCo-Founder
Life sciences techAI-powered platform for analyzing genetic variations in multiple genes involved in drug response
Founded2023Unfunded
Founders · 2
Michael ZastrozhinCo-Founder & CEO
Allan GobbsCo-Founder
Life sciences techProvider of predictive analytics tool for pharmaceutical market access
Founded2023Unfunded
Founder · 1
Armen SolakhyanFounder & CEO
Life sciences techProvider of cloud-based, no-code bioinformatics platform for single-cell genomic and proteomic analysis
Founded2023Unfunded
Founders
Details not available
OncologyDeveloper of AI-enabled technology platform for early cancer detection
Founded2022Unfunded
Founders · 3
Md Scd Ashkan AfshinFounder & CEO
Mohammad ForouzanfarCo-Founder
Nader GaminiCo-Founder
Life sciences techDeveloper of open-platform silicon biochips for life science research and diagnostics
Founded2022Unfunded
Founder · 1
Arjang HassibiCo-Founder & CEO
Life sciences techProvider of inventory planning solution for pharma and biotech companies
Founded2022Unfunded
Founders
Details not available
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.00m · Seed · Aug 2025
- Founded
- 2024 · about 2 years old
- Stage
- Seed
- Focus
- Clinical data analysis, Drug informatics, Research & development
Founders · 3
Harshit GuptaCo-Founder
Jason ParkCo-Founder & CPO
Minseok BaeCo-Founder & CEO
Investors · 3
- SK NetworksFund
- Aidan GomezAngel
- Illia PolosukhinAngel
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers31,475
Recent company signals
- Leadership Hired a Head of Business
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Ai based, Cheminformatics, Document search, Drug discovery
Founders · 6
Ziv Bar-JosephCo-Founder & Chief Scientific Officer
Emma LundbergCo-Founder
- Highest education
- MSc, Biotechnology · KTH
Eric XingCo-Founder
- Highest education
- Doctor of Philosophy · Rutgers
Le SongCo-Founder & CTO
- Highest education
- BS, Computer Science · South China University of Technology
David BakerCo-Founder
Fred HuCo-Founder & CEO
Team & hiring signals
Open roles1of 6 tracked · last posted Nov 2025
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Late Stage
- Focus
- Drugs, Retinal disorders
Founders · 4
Srinivas AkkarajuCo-Founder & Director
Napoleone FerraraCo-Founder
Samir PatelCo-Founder
Mike DybbsCo-Founder & Director
Team & hiring signals
LinkedIn headcount202-10
LinkedIn followers6,183
Recent company signals
- Milestone 2025 earnings employees
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Clinic based, Medical devices, Neurorehabilitation, Therapeutic devices
Team & hiring signals
LinkedIn headcount111-50
LinkedIn followers39
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$15.64m · Seed · Jan 2026
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Drug discovery, Proteomics, Research & development
Funding over time
US$15.64m across 3 disclosed equity rounds
Darker bars = larger roundsInvestors · 6
- InventureFund
- TesiFund
- Voima VenturesFund
- BalnordFund
- DimerentFund
Team & hiring signals
LinkedIn headcount2211-50
LinkedIn followers2,560
Open roles1of 1 tracked · last posted May 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Research & development, Image analysis, Digital pathology, Provider
Founders · 2
Webster LincolnCo-Founder & CEO
- Highest education
- MS · SJSC
Inema OrukariCo-Founder
- Highest education
- BS · SJSC
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers345
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Research & development, Drug discovery, Pharmacokinetics
Founders · 2
Michael ZastrozhinCo-Founder & CEO
Allan GobbsCo-Founder
- Highest education
- Biology · The Johns Hopkins University
Technology
- React
- Nginx
Tailwind CSS
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Business analytics, Specialty pharmaceuticals
Founders · 1
Armen SolakhyanFounder & CEO
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers206
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Drug discovery, Genomics, Research & development, Sequencing analysis
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2022 · about 4 years old
- Stage
- Unfunded
- Focus
- Diversified, In-vitro diagnostic tests
Founders · 3
Md Scd Ashkan AfshinFounder & CEO
- Highest education
- New York Academy Of Sciences
Mohammad ForouzanfarCo-Founder
Nader GaminiCo-Founder
- Highest education
- Master's of business administration · Ucla Anderson School Of Management
Team & hiring signals
LinkedIn headcount711-50
LinkedIn followers689
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2022 · about 4 years old
- Stage
- Unfunded
- Focus
- Drug discovery, Genomics, Research & development, Sequencing analysis
Founders · 1
Arjang HassibiCo-Founder & CEO
- Highest education
- MSc, Electrical Engineering · Stanford University
Team & hiring signals
LinkedIn headcount211-50
LinkedIn followers68
Patents
Patent filings6
Focus: Time-resolved fluorescence biosensors for rapid biological analyte detection
CPC G01N21/6408Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2022 · about 4 years old
- Stage
- Unfunded
- Focus
- Inventory management, Supply chain solutions
Team & hiring signals
LinkedIn headcount122-10
LinkedIn followers151
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Most covered in the news
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
OphthalmologyDeveloper of therapeutics to treat retinal diseases
News events · last 24 months27Across tracked business press
Leadership · 1
Victor PerlrothChairman and CEO
Metabolic diseasesDrug for treatment of chronic kidney disease
News events · last 24 months23Across tracked business press
Founders
Details not available
Cardiac and vascular disordersDeveloper of therapeutic devices for cardiovascular diseases
News events · last 24 months14Across tracked business press
Leadership · 1
Richard FangCEO
GenomicsGenetically engineered yeast cells to produce medicinal products
News events · last 24 months13Across tracked business press
Founders · 2
Christina SmolkeCo-Founder & CEO
Kristy HawkinsCo-Founder & CSO
Life sciences platforms and toolsTherapeutic antibody discovery company providing diverse antibody repertoires and cutting-edge screening technologies
News events · last 24 months5Across tracked business press
Founders
Details not available
OncologyDiscovering and developing small molecule drugs for the treatment of cancer
News events · last 24 months5Across tracked business press
Leadership · 1
David HansenCEO & President
Ent disordersSinus Dilation Made Simple
News events · last 24 months3Across tracked business press
Founders · 2
Thomas SchreckCo-Founder & CEO
Jerome HesterCo-Founder & CMO
Cardiac and vascular disordersDeveloper of medical devices for treating mitral valve regurgitation
News events · last 24 months3Across tracked business press
Founder · 1
Jacques EssingerFounder & CEO
PulmonologyTechnology solutions for critical care patient management, promoting health and safety
News events · last 24 months3Across tracked business press
Founders · 2
Rafael SquitieriCo-Founder & CTO
Kim OrumchianCEO, Co-Founder
OncologyDeveloper of cancer therapeutics
News events · last 24 months3Across tracked business press
Founders
Details not available
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 112 (previous snapshot 111)
- Recorded funding
- US$35.84m · Series B · Mar 2016
- Founded
- 2009 · about 17 years old
- Stage
- Public
- Focus
- Medical devices, Therapy, Retinal disorders
Funding over time
US$35.84m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Victor PerlrothChairman and CEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Team & hiring signals
LinkedIn headcount13551-200
LinkedIn followers14,700
Earlier recorded team1122022, a different source
Open roles1of 3 tracked · last posted Jan 2026
Patents
Patent filings211
Focus: Antibody‑drug conjugates and protein therapeutics targeting cytokines and ocular disease.
CPC C07K16/22, C07K16/248, C08F230/02Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 72
- Recorded funding
- US$131.00m · PE · Jul 2005
- Founded
- 2001 · about 25 years old
- Stage
- Public
- Focus
- Drugs, Renal disorders
Funding over time
US$131.00m across 3 disclosed equity rounds
Darker bars = larger roundsInvestors · 4
- ApaxFund
- Credit SuisseFund
- MPM CapitalFund
- Bear Stearns CompaniesFund
Patents
Patent filings162
Focus: Erythropoietin receptor agonist peptides and PEGylated peptide drug delivery technologies
CPC C07K14/505, C07K14/001, A61K38/1816Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2021 · about 5 years old
- Stage
- Unfunded
- Focus
- Medical devices, Therapeutic devices, Diversified
Leadership · 1
Richard FangCEO
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50 (previous snapshot 61)
- Recorded funding
- US$176.37m · Series C · Jan 2026
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- Applied genomics, Synthetic biology, Research services, Diversified
Funding over time
US$176.37m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Christina SmolkeCo-Founder & CEO
- Highest education
- Doctor of Philosophy · The University of California
Kristy HawkinsCo-Founder & CSO
Investors · 11
- EDBIFund
- EchoFund
- In-Q-TelFund
- S-Cubed CapitalFund
Team & hiring signals
LinkedIn headcount6651-200
LinkedIn followers9,936
Earlier recorded team502022, a different source
Open roles1of 7 tracked · last posted Jun 2026
- Hiring: Associate Director of Global Quality
Recent company signals
- Leadership Hired a VP of Drug Innovation and Managing Director
Patents
Patent filings82
Focus: Biotechnological production and optimization of opioid alkaloids (benzylisoquinoline and morphinan)
CPC C12N15/52, C12P17/182, C12P17/12Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 95
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Public
- Focus
- Research assays, Drug discovery, Therapeutic antibody discovery
Team & hiring signals
LinkedIn headcount7651-200
LinkedIn followers5,278
Open roles4of 8 tracked · last posted Jun 2026
Patents
Patent filings30
Focus: Therapeutic antibodies for immune checkpoints and viral targets, plus APOL1 small‑molecule inhibitors.
CPC A01K67/0278, C07K16/2818, A61P13/12Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50
- Recorded funding
- None recorded
- Founded
- 1988 · about 38 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
David HansenCEO & President
Investors · 2
GimvFund
Technology
- PHP
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 1
- Recorded funding
- None recorded
- Founded
- 2010 · about 16 years old
- Stage
- Series D
- Focus
- Medical devices, Therapeutic devices, Sinuses
Founders · 2
Thomas SchreckCo-Founder & CEO
- Highest education
- Bachelor's in american studies · Williams College
Jerome HesterCo-Founder & CMO
- Highest education
- Califonia Sleep Institute
Investors · 2
AshHillFund
Team & hiring signals
LinkedIn headcount1111-50
LinkedIn followers916
Earlier recorded team12022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 20
- Recorded funding
- US$115.00m · Series C · Mar 2026
- Founded
- 2010 · about 16 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Valvular diseases
Funding over time
US$115.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacques EssingerFounder & CEO
- Highest education
- PhD · EPFL
Investors · 8
- Decheng CapitalFund
- EarlybirdFund
- Endeavour VisionFund
- LuminationFund
- IDO InvestmentsFund
- DC Global VenturesFund
Team & hiring signals
LinkedIn headcount2511-50
LinkedIn followers745
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 34 (previous snapshot 28)
- Recorded funding
- US$15.75m · Series B · Aug 2020
- Founded
- 2011 · about 15 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Chest physiotherapy and airway clearance
Funding over time
US$15.75m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Rafael SquitieriCo-Founder & CTO
- Highest education
- Doctor of medicine in medicine · Icahn School Of Medicine At Mount Sinai
Kim OrumchianCEO, Co-Founder
- Highest education
- Bachelor's in applied physics · Columbia Engineering
Team & hiring signals
LinkedIn headcount4711-50
LinkedIn followers1,422
Patents
Patent filings138
Focus: Therapeutic compression garments with inflatable perfusion and integrated power/monitoring systems
CPC A61G7/05776, A61F13/51474, A61F5/34Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 43 (previous snapshot 62)
- Recorded funding
- None recorded
- Founded
- 2020 · about 6 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore Palo Alto life sciences companies by sub-sector
The most common specialisations among life sciences companies in Palo Alto. Open a company to see what it sells, who runs it and how far it has come.
Life sciences tech · 34
34 life sciences companies in Palo Alto work in life sciences tech. Shown: the best-documented.
Life sciences techProvider of a cloud based clinical trail management tool for researchers
Revenue modelSubscription
Founders · 3
James SasCo-Founder
Tim SmithCo-Founder, CTO
Michelle LongmireCo-Founder & CEO
Grc softwareBiorisk management platform
Revenue modelSubscription
Founder · 1
Charity DeanCo-Founder & CEO
Life sciences techAI-based RNA molecular modeling tool for the vaccine
Revenue modelSubscription
Founder · 1
Jakob UszkoreitCo-Founder & CEO
Life sciences techAI-based business development tool for healthcare
Revenue modelSubscription
Founders · 2
Lana FengCo-Founder & CEO
Greg KostelloCo-Founder & CTO
Professional service robotsAI‑driven lab automation platform
Revenue modelSubscription
Founders
Details not available
Life sciences techProvider of cloud-based AI solution for the life sciences industry
Revenue modelSubscription
Founders · 2
Michelle WuCo-Founder & CEO
Qiang KouCo-Founder
Clinical labs itAI and cloud-based microscopic image and data analysis software for clinical and researchers
Revenue modelSubscription
Founder · 1
Michael LeeCo-Founder
Life sciences techAI-powered solutions to simplify workflows in pharmaceutical research
Revenue modelSubscription
Founders · 3
Harshit GuptaCo-Founder
Jason ParkCo-Founder & CPO
Minseok BaeCo-Founder & CEO
Life sciences techDeveloper of the omic data platform for researchers
Revenue modelSubscription
Founder · 1
Mostafa RonaghiCo-Founder
Life sciences techAI-powered platform for drug screening and development
Revenue modelSubscription
Founder · 1
Christopher MoxhamFounder & CEO
Life sciences techBiotechnology company that employs protein engineering solutions
Revenue modelSubscription
Founders
Details not available
Life sciences techDeveloper of AI-driven enzyme and targeted drug design for therapeutics
Revenue modelSubscription
Founders
Details not available
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 376
- Recorded funding
- US$518.45m · Series D · Oct 2021
- Founded
- 2012 · about 14 years old
- Stage
- Series D
- Focus
- Research & development, Clinical trials, Study implementation, Ctms and edc
Funding over time
US$518.45m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 3
James SasCo-Founder
Tim SmithCo-Founder, CTO
- Highest education
- Bachelor's · The University Of Texas At Austin
Michelle LongmireCo-Founder & CEO
- Highest education
- Stanford University School Of Medicine
Investors · 8
- BlackstoneFund
- GSR VenturesFund
- Obvious VenturesFund
- PPDFund
- WTIFund
Team & hiring signals
LinkedIn headcount341501-1,000
LinkedIn followers120,886
Earlier recorded team3762022, a different source
Open roles1of 3 tracked · last posted Nov 2025
Patents
Patent filings14
Focus: Digital health data integration, remote patient monitoring, and HIPAA compliance automation
CPC G16H50/20, G06Q10/0639, G16H80/00Mobile apps
- MedableMedical · 4,345 installs · ★ 4.0 · updated 2026-06-05
- ZEUS Study App (EX6018-4758)Medical · 3,456 installs · updated 2024-10-08
- P23-899 PatientMedical · 673 installs · updated 2025-03-10
Technology
- AWS
- React
- Nginx
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48
- Recorded funding
- US$13.02m · Seed · Apr 2021
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Risk management, Integrated risk management, Grc solutions, Biorisk managment
Funding over time
US$13.02m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Charity DeanCo-Founder & CEO
- Highest education
- Tulane University
Investors · 3
Team & hiring signals
LinkedIn headcount4651-200
LinkedIn followers3,255
Open roles3of 6 tracked · last posted Feb 2026
Technology
- Cloudflare
- HubSpot
- Firebase
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 35 (previous snapshot 30)
- Recorded funding
- US$120.00m · Series A · Sep 2023
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Vaccine discovery, Ai based
Funding over time
US$120.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jakob UszkoreitCo-Founder & CEO
- Highest education
- TU Berlin
Investors · 3
- Obvious VenturesFund
- NVIDIAFund
Team & hiring signals
LinkedIn headcount5511-50
LinkedIn followers10,432
Open roles0of 1 tracked · last posted Apr 2025
Recent company signals
- Partnership Partnership with Alnylam Pharmaceuticals
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 25)
- Recorded funding
- US$15.01m · Series A · Mar 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Provider, Administrative solutions, Business and market intelligence, Business intelligence
Funding over time
US$15.01m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Lana FengCo-Founder & CEO
- Highest education
- University Of California, San Diego - School Of Medicine
Greg KostelloCo-Founder & CTO
Investors · 9
- Fusion FundFund
- Human LongevityFund
- ShangBay CapitalFund
- The King's FundFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers3,254
Technology
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 55)
- Recorded funding
- US$21.50m · Series A · May 2021
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Tech enablers, Software, No code robotic programming, Machine intelligence systems
Investors · 3
- M12Fund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers5,125
Earlier recorded team262022, a different source
Recent company signals
- Launch Launched Tips (AI assistant for lab systems)
Patents
Patent filings97
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G06N20/00, G06N3/084, G16C20/50Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 17
- Recorded funding
- US$6.00m · Seed · Mar 2022
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Data analysis platforms
Founders · 2
Michelle WuCo-Founder & CEO
- Highest education
- Master's of Business Administration · Stanford Graduate School of Business
Qiang KouCo-Founder
- Highest education
- PhD · IUPUI
Investors · 3
- GSR VenturesFund
Team & hiring signals
LinkedIn headcount1311-50
LinkedIn followers2,435
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 7 (previous snapshot 2)
- Recorded funding
- US$125k · Seed · Jan 2021
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Pathology, Image analysis, Ai based, Research & development
Founders · 1
Michael LeeCo-Founder
- Highest education
- Bachelor's in computer science · Stanford University
Investors · 1
- Y CombinatorFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers1,611
Earlier recorded team72022, a different source
Open roles1of 1 tracked · last posted Nov 2025
- Hiring: Mid/Senior Fullstack Engineer · Asana, Astana
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.00m · Seed · Aug 2025
- Founded
- 2024 · about 2 years old
- Stage
- Seed
- Focus
- Clinical data analysis, Drug informatics, Research & development
Founders · 3
Harshit GuptaCo-Founder
Jason ParkCo-Founder & CPO
Minseok BaeCo-Founder & CEO
Investors · 3
- SK NetworksFund
- Aidan GomezAngel
- Illia PolosukhinAngel
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers31,475
Recent company signals
- Leadership Hired a Head of Business
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$42.71m · Series A · Mar 2023
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Funding over time
US$42.71m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mostafa RonaghiCo-Founder
- Highest education
- Doctor of Philosophy · KTH
Team & hiring signals
LinkedIn headcount12851-200
LinkedIn followers6,032
Patents
Patent filings77
Focus: Microfluidic cell analysis, sorting, and multiplex assay platforms for engineered cell screening
CPC B01L3/502715, C12Q1/6806, G01N33/54386Technology
- AWS
- Cloudflare
- Salesforce
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$1.00m · Series A · Apr 2024
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Founders · 1
Christopher MoxhamFounder & CEO
- Highest education
- Doctor of Philosophy, Pharmacology · Stony Brook University
Investors · 2
- BlueYardFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers3,926
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$15.64m · Seed · Jan 2026
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Drug discovery, Proteomics, Research & development
Funding over time
US$15.64m across 3 disclosed equity rounds
Darker bars = larger roundsInvestors · 6
- InventureFund
- TesiFund
- Voima VenturesFund
- BalnordFund
- DimerentFund
Team & hiring signals
LinkedIn headcount2211-50
LinkedIn followers2,560
Open roles1of 1 tracked · last posted May 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$25.00m · Seed · Sep 2025
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Ai based, Cheminformatics, Drug discovery, Lead discovery
Investors · 2
- Overlap HoldingsFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences platforms and tools · 19
19 life sciences companies in Palo Alto work in life sciences platforms and tools. Shown: the best-documented.
GenomicsGenetically engineered yeast cells to produce medicinal products
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Christina SmolkeCo-Founder & CEO
Kristy HawkinsCo-Founder & CSO
GenomicsDeveloper of DNA chips and molecular assays
Revenue modelFee-for-service
Founder · 1
Wei ZhouFounder & CEO
Life sciences platforms and toolsTools for innovations in oncology and cell therapy research
Revenue modelSubscription
Founders · 3
Caleb Branson BellCo-Founder & CTO
Dan BellCo-Founder & CFO
Ken HarrisCo-Founder & CEO
Life sciences platforms and toolsDeveloper of immune-competent human-derived models for drug development
Revenue modelPhysical commerce
Founders · 3
Calvin KuoCo-Founder
Mark DavisCo-Founder
Adam MargolinCo-Founder & CEO
Life sciences platforms and toolsTherapeutics using polymers of hyaluronic acid for pain management.
Revenue modelE-commerce - product / Physical commerce
Leadership · 2
David RenziCEO
Andrew CrockettCEO
Life sciences platforms and toolsProprietary delivery technology to send large molecules through tissue structures
Revenue modelPhysical commerce
Founders
Details not available
Cell therapyDeveloper of machine learning cell imaging platform for regenerative medicines
Revenue modelAdvertising / Commission on transaction
Founders
Details not available
Life sciences platforms and toolsDeveloper of protein sequencing technology using silicon photonics and machine learning
Revenue modelSubscription
Founders · 3
Jennifer DionneCo-Founder
Jack HuCo-Founder
Nhat VuCo-Founder
Life sciences techDeveloper of the omic data platform for researchers
Revenue modelSubscription
Founder · 1
Mostafa RonaghiCo-Founder
Life sciences platforms and toolsTherapeutic antibody discovery company providing diverse antibody repertoires and cutting-edge screening technologies
Revenue modelPhysical commerce
Founders
Details not available
Life sciences platforms and toolsDeveloper of technology for biomolecular detection
Revenue modelSubscription
Founders · 2
Hong TanCo-Founder & CEO
Robert ZukCo-Founder
GenomicsDeveloper of PCR platform for true quantitation with multiplexing capabilities
Revenue modelSubscription
Founders · 3
Christina FCo-Founder
Stephen FodorCo-Founder & CEO
Ari ChaneyCo-Founder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50 (previous snapshot 61)
- Recorded funding
- US$176.37m · Series C · Jan 2026
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- Applied genomics, Synthetic biology, Research services, Diversified
Funding over time
US$176.37m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Christina SmolkeCo-Founder & CEO
- Highest education
- Doctor of Philosophy · The University of California
Kristy HawkinsCo-Founder & CSO
Investors · 11
- EDBIFund
- EchoFund
- In-Q-TelFund
- S-Cubed CapitalFund
Team & hiring signals
LinkedIn headcount6651-200
LinkedIn followers9,936
Earlier recorded team502022, a different source
Open roles1of 7 tracked · last posted Jun 2026
- Hiring: Associate Director of Global Quality
Recent company signals
- Leadership Hired a VP of Drug Innovation and Managing Director
Patents
Patent filings82
Focus: Biotechnological production and optimization of opioid alkaloids (benzylisoquinoline and morphinan)
CPC C12N15/52, C12P17/182, C12P17/12Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 36)
- Recorded funding
- US$103.30m · Series C · Jul 2018
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Research services, Genomics, Genomics services, Full service
Funding over time
US$86.80m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Wei ZhouFounder & CEO
- Highest education
- Leadership · Harvard Business School
Investors · 1
- WeDoctorFund
Team & hiring signals
Open roles4of 23 tracked · last posted May 2026
Patents
Patent filings6
Focus: High-throughput DNA sequencing reagents, microarray fabrication, and surface-modified platforms
CPC B01J19/0046, C12Q1/6874, G01N35/1002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12
- Recorded funding
- US$3.93m · Series A · Apr 2015
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- Research services, Diversified
Funding over time
US$3.93m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Caleb Branson BellCo-Founder & CTO
Dan BellCo-Founder & CFO
Ken HarrisCo-Founder & CEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 8 (previous snapshot 9)
- Recorded funding
- US$7.90m · Series A · Dec 2021
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research assays, Drug discovery, Organoid models
Founders · 3
Calvin KuoCo-Founder
Mark DavisCo-Founder
Adam MargolinCo-Founder & CEO
- Highest education
- Doctor of Philosophy · Columbia University
Investors · 3
- AlexandriaFund
- Khosla VenturesFund
Team & hiring signals
LinkedIn headcount22-10
LinkedIn followers844
Earlier recorded team82022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 7
- Recorded funding
- US$42.90m · Series C · Mar 2015
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Drugs, Pain, Research services, Diversified
Funding over time
US$42.90m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 2
David RenziCEO
Andrew CrockettCEO
- Highest education
- Master's of science · Ucl
Investors · 3
- Alta PartnersFund
- Vivo CapitalFund
Team & hiring signals
LinkedIn headcount2
LinkedIn followers103
Earlier recorded team72022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 5
- Recorded funding
- US$5.00m · Series A · Feb 2017
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Diversified, Research services
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Advertising, Commission on transaction, E-commerce - service
- Team size
- Not available
- Recorded funding
- US$12.00m · Seed · May 2025
- Founded
- 2021 · about 5 years old
- Stage
- Seed
- Focus
- Diversified, Drugs, Imaging systems, Instruments
Investors · 11
- AIX VenturesFund
- AxialFund
- BoxOne VenturesFund
- DimensionFund
- Village GlobalFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$20.00m · Series A · May 2026
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Proteomics, Research services
Founders · 3
Jennifer DionneCo-Founder
- Highest education
- Bachelor's of Science (B.S.), Systems Science and Engineering; Physics · WashU
Jack HuCo-Founder
Nhat VuCo-Founder
Investors · 5
- Analog DevicesFund
- Future VenturesFund
- NFXFund
- Base4 CapitalFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$42.71m · Series A · Mar 2023
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Funding over time
US$42.71m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mostafa RonaghiCo-Founder
- Highest education
- Doctor of Philosophy · KTH
Team & hiring signals
LinkedIn headcount12851-200
LinkedIn followers6,032
Patents
Patent filings77
Focus: Microfluidic cell analysis, sorting, and multiplex assay platforms for engineered cell screening
CPC B01L3/502715, C12Q1/6806, G01N33/54386Technology
- AWS
- Cloudflare
- Salesforce
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 95
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Public
- Focus
- Research assays, Drug discovery, Therapeutic antibody discovery
Team & hiring signals
LinkedIn headcount7651-200
LinkedIn followers5,278
Open roles4of 8 tracked · last posted Jun 2026
Patents
Patent filings30
Focus: Therapeutic antibodies for immune checkpoints and viral targets, plus APOL1 small‑molecule inhibitors.
CPC A01K67/0278, C07K16/2818, A61P13/12Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 57 (previous snapshot 49)
- Recorded funding
- None recorded
- Founded
- 2020 · about 6 years old
- Stage
- Unfunded
- Focus
- Imaging systems, Instruments, Microscopy, Optical microscopy
Founders · 2
Hong TanCo-Founder & CEO
Robert ZukCo-Founder
Team & hiring signals
LinkedIn headcount7251-200
LinkedIn followers7,651
Open roles2of 5 tracked · last posted Apr 2026
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15
- Recorded funding
- None recorded
- Founded
- 2019 · about 7 years old
- Stage
- Funding Raised
- Focus
- Instruments, Genomics, Pcr, Digital pcr
Founders · 3
Christina FCo-Founder
Stephen FodorCo-Founder & CEO
Ari ChaneyCo-Founder
Team & hiring signals
LinkedIn headcount4811-50
LinkedIn followers3,140
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Oncology · 18
18 life sciences companies in Palo Alto work in oncology. Shown: the best-documented.
OncologyDeveloper of biotherapeutic solutions for cancer treatment
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
Dongxu SunCEO
OncologyDeveloper of RNA biomarkers and AI platform for cancer detection
Revenue modelSubscription
Founders · 2
Babak AlipanahiCo-Founder & Chief Scientific Officer
Hani GoodarziCo-Founder
ImmunotherapyDeveloper of antibodies to target immune system and tumor microenvironment
Revenue modelFee-for-service
Founder · 1
Charlene LiaoFounder & CEO
ImmunotherapyDeveloper of immunotherapeutics for cancer treatment
Revenue modelSubscription
Founder · 1
Roy MauteCo-Founder
PulmonologyDeveloper of therapeutics for the treatment of inflammatory and rare diseases
Revenue modelSubscription
Founder · 1
Ritu LalCo-Founder & CEO
OncologyDeveloper of Immunotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infections
Revenue modelFee-for-service
Leadership · 1
Ben BuelowCEO
OncologySmall molecule drug conjugates to treat cancer
Revenue modelSubscription
Founder · 1
Steven EverettFounder, President & CEO
OncologyRayont provides healthcare solutions focusing on the manufacture of alternative medicinal products and services.
Revenue modelSubscription
Founders
Details not available
OncologyDiscovering and developing small molecule drugs for the treatment of cancer
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
David HansenCEO & President
OncologyDeveloper of cancer therapeutics
Revenue modelE-commerce - product / Physical commerce
Founders
Details not available
Life sciences techDeveloper of AI-based precision medicines for cancer
Revenue modelSubscription
Founder · 1
Pek LumFounder and CEO
OncologyPrecision targeting for radiation therapy.
Revenue modelFee-for-service
Founders · 2
Jeff SchlosserFounder
Dimitre HristovCo-Founder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 89
- Recorded funding
- US$169.85m · Series D · Sep 2022
- Founded
- 2015 · about 11 years old
- Stage
- Series D
- Focus
- Drugs, Diversified
Funding over time
US$169.85m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dongxu SunCEO
- Highest education
- Doctorates in philosophy · University Of Minnesota
Team & hiring signals
LinkedIn headcount3451-200
LinkedIn followers5,790
Earlier recorded team892021, a different source
Recent company signals
- Milestone 380 patients enrolled
- Milestone more than 50% patients recruited
Patents
Patent filings80
Focus: Therapeutic antibodies targeting Galectin‑3 and protein‑aggregation inhibition for disease treatment
CPC C07K16/2851, C07K16/2803, A61P31/14Technology
- Angular
- TypeScript
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 47 (previous snapshot 55)
- Recorded funding
- US$138.15m · Series B · Oct 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- In-vitro diagnostic tests, Diversified
Funding over time
US$138.15m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Babak AlipanahiCo-Founder & Chief Scientific Officer
- Highest education
- Computer Science · University of Waterloo
Hani GoodarziCo-Founder
Investors · 3
- Casdin CapitalFund
- S32Fund
Team & hiring signals
LinkedIn headcount2251-200
LinkedIn followers6,287
Open roles1of 1 tracked · last posted May 2026
Recent company signals
- Partnership Partnership with Deviation Capital
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 24 (previous snapshot 46)
- Recorded funding
- US$138.00m · Series B · Jan 2023
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$138.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Charlene LiaoFounder & CEO
- Highest education
- Northwestern University - Kellogg School Of Management
Investors · 12
- CLI VenturesFund
- Proxima VenturesFund
- Triwise CapitalFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers4,018
Earlier recorded team242022, a different source
Technology
- Cloudflare
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 20
- Recorded funding
- US$101.22m · Series C · Oct 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$101.22m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Roy MauteCo-Founder
- Highest education
- Doctorates in genetics · Columbia University In The City Of New York
Investors · 4
- AlexandriaFund
- Stanford University Presidential Venture FundFund
Team & hiring signals
LinkedIn headcount4111-50
LinkedIn followers5,621
Recent company signals
- Launch Launched PHST677 (advanced bispecific ADC targeting CDH1 (E-cadherin) and Nectin-4)
Technology
- Cloudflare
- Zendesk
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 15)
- Recorded funding
- US$22.67m · Series A · Oct 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Inflammatory diseases, Diversified
Funding over time
US$22.67m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Ritu LalCo-Founder & CEO
Investors · 2
- Clear VenturesFund
- Y CombinatorFund
Team & hiring signals
LinkedIn headcount192-10
LinkedIn followers1,095
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 12
- Recorded funding
- US$60.00m · Series A · Jun 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Viral, Hepatitis
Leadership · 1
Ben BuelowCEO
- Highest education
- MD, Immunology · University of Washington
Investors · 2
- SR OneFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 3
- Recorded funding
- US$7.50m · Series A · Oct 2019
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$7.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Steven EverettFounder, President & CEO
Investors · 2
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers280
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 58
- Recorded funding
- None recorded
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Team & hiring signals
LinkedIn headcount151-200
LinkedIn followers70
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50
- Recorded funding
- None recorded
- Founded
- 1988 · about 38 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
David HansenCEO & President
Investors · 2
- GimvFund
Technology
- PHP
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 43 (previous snapshot 62)
- Recorded funding
- None recorded
- Founded
- 2020 · about 6 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12 (previous snapshot 14)
- Recorded funding
- None recorded
- Founded
- 2014 · about 12 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Cheminformatics, In-vitro diagnostic tests
Founders · 1
Pek LumFounder and CEO
Investors · 1
Lux CapitalFund
Team & hiring signals
LinkedIn headcount1111-50
LinkedIn followers966
Patents
Patent filings48
Focus: Patents concentrated in chemistry & materials
CPC C07D213/81, A61K31/352, A61K31/135Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 7
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Funding Raised
- Focus
- Medical devices, Therapies, Radiation therapy
Founders · 2
Jeff SchlosserFounder
Dimitre HristovCo-Founder
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Genomics · 17
17 life sciences companies in Palo Alto work in genomics. Shown: the best-documented.
GenomicsGenetically engineered yeast cells to produce medicinal products
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Christina SmolkeCo-Founder & CEO
Kristy HawkinsCo-Founder & CSO
GenomicsDeveloper of silicon-based nanomachine chips
Revenue modelSubscription
Founders · 3
Greg SittersCo-Founder
Steven BanerjeeCo-Founder & CEO
Anil NarasimhaCo-Founder & CSO
GenomicsDeveloper of DNA chips and molecular assays
Revenue modelFee-for-service
Founder · 1
Wei ZhouFounder & CEO
GenomicsProvider of DNA sequencing based personalised medicine
Revenue modelSubscription
Founder · 1
Daniel UribeCo-Founder & CEO
Life sciences techDeveloper of the omic data platform for researchers
Revenue modelSubscription
Founder · 1
Mostafa RonaghiCo-Founder
GenomicsBioinformatics company accelerating life science research through innovative software solutions
Revenue modelSubscription
Leadership · 1
Arun ApteCEO
Life sciences techInnovative tools and services for molecular and cell biology research
Revenue modelSubscription
Founders
Details not available
GenomicsDeveloper of PCR platform for true quantitation with multiplexing capabilities
Revenue modelSubscription
Founders · 3
Christina FCo-Founder
Stephen FodorCo-Founder & CEO
Ari ChaneyCo-Founder
Life sciences techDeveloper of AI-based precision medicines for cancer
Revenue modelSubscription
Founder · 1
Pek LumFounder and CEO
Life sciences techProvider of AI-based bioinformatic platform for genomic data analysis
Revenue modelSubscription
Leadership · 1
Shuang WangCEO
GenomicsMitochondrial genetic test, software applications for personalized cancer radiotherapy
Revenue modelFee-for-service
Founder · 1
Syed HamdaniFounder & CEO
GenomicsLife science products: antibodies, assay kits, DNA templates, and related reagents
Revenue modelSubscription
Leadership · 1
Arun ApteCEO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 50 (previous snapshot 61)
- Recorded funding
- US$176.37m · Series C · Jan 2026
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- Applied genomics, Synthetic biology, Research services, Diversified
Funding over time
US$176.37m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Christina SmolkeCo-Founder & CEO
- Highest education
- Doctor of Philosophy · The University of California
Kristy HawkinsCo-Founder & CSO
Investors · 11
- EDBIFund
- EchoFund
- In-Q-TelFund
- S-Cubed CapitalFund
Team & hiring signals
LinkedIn headcount6651-200
LinkedIn followers9,936
Earlier recorded team502022, a different source
Open roles1of 7 tracked · last posted Jun 2026
- Hiring: Associate Director of Global Quality
Recent company signals
- Leadership Hired a VP of Drug Innovation and Managing Director
Patents
Patent filings82
Focus: Biotechnological production and optimization of opioid alkaloids (benzylisoquinoline and morphinan)
CPC C12N15/52, C12P17/182, C12P17/12Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48 (previous snapshot 43)
- Recorded funding
- US$29.60m · Series A · Nov 2021
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Enabling technologies, Technology platforms, Gene delivery, Actuators
Funding over time
US$29.60m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Greg SittersCo-Founder
- Highest education
- Macquarie Graduate School On Management
Steven BanerjeeCo-Founder & CEO
Anil NarasimhaCo-Founder & CSO
- Highest education
- Doctorates, Biology · Uc San Diego
Investors · 14
- CRCM VenturesFund
- DebiopharmFund
- Good AI CapitalFund
- Hike VenturesFund
- MagnetarFund
- NovartisFund
- PEAK6Fund
Team & hiring signals
LinkedIn headcount611-50
LinkedIn followers2,096
Patents
Patent filings49
Focus: Patents concentrated in transport & manufacturing processes
CPC B01L3/502761, B81B1/002, G03F7/0035Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 36)
- Recorded funding
- US$103.30m · Series C · Jul 2018
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Research services, Genomics, Genomics services, Full service
Funding over time
US$86.80m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Wei ZhouFounder & CEO
- Highest education
- Leadership · Harvard Business School
Investors · 1
- WeDoctorFund
Team & hiring signals
Open roles4of 23 tracked · last posted May 2026
Patents
Patent filings6
Focus: High-throughput DNA sequencing reagents, microarray fabrication, and surface-modified platforms
CPC B01J19/0046, C12Q1/6874, G01N35/1002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 9 (previous snapshot 7)
- Recorded funding
- US$650k · Seed · Jul 2020
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$650k across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Daniel UribeCo-Founder & CEO
- Highest education
- Communication · General Assembly
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers1,127
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$42.71m · Series A · Mar 2023
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Funding over time
US$42.71m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mostafa RonaghiCo-Founder
- Highest education
- Doctor of Philosophy · KTH
Team & hiring signals
LinkedIn headcount12851-200
LinkedIn followers6,032
Patents
Patent filings77
Focus: Microfluidic cell analysis, sorting, and multiplex assay platforms for engineered cell screening
CPC B01L3/502715, C12Q1/6806, G01N33/54386Technology
- AWS
- Cloudflare
- Salesforce
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 31)
- Recorded funding
- None recorded
- Founded
- 1994 · about 32 years old
- Stage
- Unfunded
- Focus
- Diversified, Genome informatics, Integrative bioinformatics platforms
Leadership · 1
Arun ApteCEO
Team & hiring signals
LinkedIn headcount2151-200
LinkedIn followers1,462
Technology
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 25 (previous snapshot 33)
- Recorded funding
- None recorded
- Founded
- 2004 · about 22 years old
- Stage
- Funding Raised
- Focus
- Research & development, Drug discovery, Genomics, Sequencing analysis
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers3,735
Recent company signals
- Launch Launched ExoQuick-TC UltraPure (EQ-TC UltraPure) (EV isolation from tissue culture media)
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15
- Recorded funding
- None recorded
- Founded
- 2019 · about 7 years old
- Stage
- Funding Raised
- Focus
- Instruments, Genomics, Pcr, Digital pcr
Founders · 3
Christina FCo-Founder
Stephen FodorCo-Founder & CEO
Ari ChaneyCo-Founder
Team & hiring signals
LinkedIn headcount4811-50
LinkedIn followers3,140
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12 (previous snapshot 14)
- Recorded funding
- None recorded
- Founded
- 2014 · about 12 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Cheminformatics, In-vitro diagnostic tests
Founders · 1
Pek LumFounder and CEO
Investors · 1
- Lux CapitalFund
Team & hiring signals
LinkedIn headcount1111-50
LinkedIn followers966
Patents
Patent filings48
Focus: Patents concentrated in chemistry & materials
CPC C07D213/81, A61K31/352, A61K31/135Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 4 (previous snapshot 7)
- Recorded funding
- None recorded
- Founded
- 2018 · about 8 years old
- Stage
- Funding Raised
- Focus
- Genome informatics, Integrative bioinformatics platforms, Research & development, Drug discovery
Leadership · 1
Shuang WangCEO
- Highest education
- Doctorates in computer engineering · University Of Oklahoma
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers89
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2015 · about 11 years old
- Stage
- Unfunded
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Founders · 1
Syed HamdaniFounder & CEO
- Highest education
- Master's in electrical engineering · University Of Missouri - Columbia
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers133
Technology
- PHP
- MySQL
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 1998 · about 28 years old
- Stage
- Unfunded
- Focus
- Genome informatics, Integrative bioinformatics platforms, Research & development, Drug discovery
Leadership · 1
Arun ApteCEO
- Highest education
- Bachelor's in molecular biology · University Of California, Berkeley
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore more lists: nearby cities and other sectors in Palo Alto
85 more company lists you can search, plus the Radar directory pages for each place.
Life sciences in nearby cities
- Oakland33 life sciences companiesExplore on Radar
- San Jose110 life sciences companiesExplore on Radar
- Palo Alto165 life sciences companiesExplore on Radar
- Mountain View112 life sciences companiesExplore on Radar
- Santa Clara70 life sciences companiesExplore on Radar
- Sunnyvale123 life sciences companiesExplore on Radar
- San Mateo49 life sciences companiesExplore on Radar
- Redwood City107 life sciences companiesExplore on Radar
- Berkeley109 life sciences companiesExplore on Radar
- Santa Monica35 life sciences companiesExplore on Radar
- San Diego847 life sciences companiesExplore on Radar
- Los Angeles286 life sciences companiesExplore on Radar
Life sciences in other US cities
- New York City665 life sciences companiesExplore on Radar
- Chicago205 life sciences companiesExplore on Radar
- Austin221 life sciences companiesExplore on Radar
- Boston537 life sciences companiesExplore on Radar
- Miami106 life sciences companiesExplore on Radar
- Seattle247 life sciences companiesExplore on Radar
- Denver82 life sciences companiesExplore on Radar
- Atlanta133 life sciences companiesExplore on Radar
- Houston240 life sciences companiesExplore on Radar
- Dallas104 life sciences companiesExplore on Radar
- Philadelphia207 life sciences companiesExplore on Radar
- Washington435 life sciences companiesExplore on Radar
Other sectors in Palo Alto
- Enterprise Applications Companies in Palo Alto, United States 659
- High Tech Companies in Palo Alto, United States 462
- Investment Industry Companies in Palo Alto, United States 359
- Enterprise Infrastructure Companies in Palo Alto, United States 315
- Consumer Companies in Palo Alto, United States 310
- Venture Capital Funds Companies in Palo Alto, United States 243
- FinTech Companies in Palo Alto, United States 233
- Native AI Companies in Palo Alto, United States 223
- Artificial Intelligence Companies in Palo Alto, United States 211
- HealthTech Companies in Palo Alto, United States 192
- Media & Entertainment Companies in Palo Alto, United States 166
- Retail Companies in Palo Alto, United States 159
- Business Services Companies in Palo Alto, United States 144
- Cybersecurity Companies in Palo Alto, United States 133
- MarketingTech Companies in Palo Alto, United States 116
- EdTech Companies in Palo Alto, United States 97
- Internet of Things - Industry Applications Companies in Palo Alto, United States 94
- HRTech Companies in Palo Alto, United States 86
- Healthcare IT Companies in Palo Alto, United States 82
- Blockchain Technology Companies in Palo Alto, United States 79
- AI Infrastructure Companies in Palo Alto, United States 78
- Chatbots Companies in Palo Alto, United States 68
- Mobile Companies in Palo Alto, United States 67
- Social Platforms Companies in Palo Alto, United States 67
- Enterprise Collaboration Companies in Palo Alto, United States 64
- K-12 EdTech Companies in Palo Alto, United States 62
- Auto Tech Companies in Palo Alto, United States 60
- Security & Surveillance Technology Companies in Palo Alto, United States 55
- Big Data Analytics Companies in Palo Alto, United States 54
- E-Commerce Enablers Companies in Palo Alto, United States 54
- Investment Tech Companies in Palo Alto, United States 52
- Enterprise Software Companies in Palo Alto, United States 51
- Business Intelligence Companies in Palo Alto, United States 51
- Sales Force Automation Companies in Palo Alto, United States 50
- Healthcare Companies in Palo Alto, United States 49
- Transportation and Logistics Tech Companies in Palo Alto, United States 49
- Food and Agriculture Tech Companies in Palo Alto, United States 47
- Semiconductors Companies in Palo Alto, United States 47
- Sustainability Tech Companies in Palo Alto, United States 45
- Energy Tech Companies in Palo Alto, United States 44
- Customer Service Software Companies in Palo Alto, United States 43
- Cryptocurrencies Companies in Palo Alto, United States 42
- IT Operations Companies in Palo Alto, United States 42
- Travel and Hospitality Tech Companies in Palo Alto, United States 41
- Private Equity Funds Companies in Palo Alto, United States 41
- Payments Companies in Palo Alto, United States 41
- Blockchain Infrastructure Companies in Palo Alto, United States 41
- Financial Services Companies in Palo Alto, United States 40
- Disease Self Management Companies in Palo Alto, United States 39
- GRC Software Companies in Palo Alto, United States 39
- Generative AI Companies in Palo Alto, United States 37
- IT Services Companies in Palo Alto, United States 36
- Real Estate and Construction Tech Companies in Palo Alto, United States 36
- SaaS Companies in Palo Alto, United States 36
- AdTech Companies in Palo Alto, United States 34
- Aerospace, Maritime and Defense Tech Companies in Palo Alto, United States 34
- Application Development Tools Companies in Palo Alto, United States 33
- Fitness & Wellness Tech Companies in Palo Alto, United States 33
- Life Sciences Tech Companies in Palo Alto, United States 33
- Logistics Tech Companies in Palo Alto, United States 33
- Wearable Technology Companies in Palo Alto, United States 33
No list matches. Try a shorter word.